ILD, hospital admissions

ILD_HOSPITAL

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J84 Hospital discharge: ICD-9 — 515\|516 Hospital discharge: ICD-8 — 48499\|51701 1 out of 7 registries used, show all original rules.	6398
4. Check minimum number of events None	6398
5. Include endpoints None	6398
6. Filter based on genotype QC (FinnGen only)	6224

Control definitions (FinnGen only)

Control exclude: ILD_HOSPITAL_PULM_INFECT

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J80-J84
Name in latin: Alii morbi interstitiales pulmonum

NAME	ILD_HOSPITAL
CONTROL_EXCLUDE	ILD_HOSPITAL_PULM_INFECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J84
HD_ICD_9	515\|516
HD_ICD_8	48499\|51701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6224	2491	3733
Unadjusted period prevalence (%)	1.38	0.88	1.71
Median age at first event (years)	69.77	67.41	71.34

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6398: Matched controls
63980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.7

318.6

800

1871

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.1

315.8

995

2767

R03AC02

ATC

salbutamol; inhalant

2.7

313.1

4012

24517

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.8

307.7

1483

3788

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.9

307.7

809

1852

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.6

307.7

4461

24797

UGC12

NOMESCO Finland

Flexible bronchoscopy

10.4

307.7

2225

3111

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.8

307.7

2363

4490

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

75.8

307.7

248

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

9.8

307.7

680

767

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.1

307.7

3370

13567

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

1664.6

307.7

3004

XG410

NOMESCO Finland

Flow-volume spirometry

8.3

307.7

878

1196

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.3

307.7

982

1801

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

24.6

307.7

2293

1421

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

592

GD1AD

NOMESCO Finland

Thorax CT examination

7.2

307.7

1218

2022

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

12784.5

307.7

1856

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

610

J96.1

ICD-10 Finland

Chronic respiratory failure

8.6

307.7

547

687

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4403.2

307.7

3450

TGC00

NOMESCO Finland

Bronchial lavation

32.3

307.7

1453

576

L04AX05

ATC

pirfenidone; oral

+∞

307.7

389

L04AX01

ATC

azathioprine; systemic

7.8

307.7

721

1030

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

23.9

307.7

344

152

H02AB06

ATC

prednisolone; systemic

5.3

307.7

4815

23344

R06.0

ICD-10 Finland

Dyspnoea

3.2

307.7

2822

12644

L04AA06

ATC

mycophenolic acid; systemic

14.8

307.7

472

342

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

17.1

307.7

1059

734

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

32.5

307.7

271

L01EX09

ATC

nintedanib; oral

+∞

302.5

288

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

298.2

3008

16253

Z94.2

ICD-10 Finland

Lung transplant status

94.0

281.8

147

P01BA02

ATC

hydroxychloroquine; oral

3.9

267.9

882

2517

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.3

259.7

1150

3978

J01MA14

ATC

moxifloxacin; systemic

3.4

246.5

1018

3366

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.4

246.1

670

1659

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.1

231.2

690

1828

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

6.0

228.6

417

730

L01XE31

ATC

[U] nintedanib

+∞

216.9

207

R03BB04

ATC

tiotropium bromide; inhalant

2.8

205.1

1188

4741

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

21.3

202.8

152

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

1802.3

191.5

185

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.5

185.4

483

1150

GX1K5

NOMESCO Finland

Diffusion capacity

17.7

182.9

149

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

179.6

1650

8170

GX1D5

NOMESCO Finland

Flow volume spirometry

41.0

173.8

105

A02BC02

ATC

pantoprazole; systemic

2.2

169.4

4744

35914

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.6

167.9

199

213

M05BA04

ATC

alendronic acid; oral

2.9

167.7

905

3452

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

10.3

167.6

189

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

164.3

157

C03CA01

ATC

furosemide; systemic

2.0

163.3

2896

18432

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.5

150.8

219

301

R05

ICD-10 Finland

Cough

2.2

150.0

1636

8615

L04AA13

ATC

[U] leflunomide

5.5

148.0

295

559

L04AX03

ATC

methotrexate; systemic

2.9

147.6

800

3048

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

146.8

1473

7491

J47

ICD-10 Finland

Bronchiectasis

5.5

145.3

288

543

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.2

139.6

605

2029

R03AK08

ATC

formoterol and beclometasone; inhalant

3.9

136.0

426

1158

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.4

133.9

354

849

A07EC01

ATC

sulfasalazine; oral, rectal

2.9

133.4

683

2517

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

132.1

1021

4619

J43.9

ICD-10 Finland

Emphysema, unspecified

5.5

130.4

256

478

GDG10

NOMESCO Finland

Bilateral transplantation of lung

270.3

129.6

132

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

129.6

124

J01MA12

ATC

levofloxacin; systemic

2.1

129.6

1599

8764

XX4BW, ,

NOMESCO Finland

41.0

127.4

L01BA01

ATC

methotrexate; systemic

4.0

127.1

383

1012

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

426.0

126.3

126

R02

ICPC

Shortness of breath/dyspnoea

2.3

124.4

1116

5378

WX721

NOMESCO Finland

Oxygen concentrator therapy

24.1

123.5

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.6

123.1

159

190

L04AD01

ATC

ciclosporin; systemic

6.0

120.5

216

370

R03BA08

ATC

ciclesonide; inhalant

2.8

117.1

668

2600

127

Kela drug reimbursment

Transplant complication

6.6

114.6

186

288

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.9

113.9

256

538

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

113.0

1918

11669

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.5

109.1

214

399

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

107.4

1369

7527

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.9

106.5

237

494

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.6

105.5

365

1059

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

105.3

1030

5115

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

104.2

1426

8030

WX892

NOMESCO Finland

Monitored bed care

2.5

103.9

709

3008

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.5

103.8

259

593

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

10.4

103.7

115

112

R50.9

ICD-10 Finland

Fever, unspecified

2.1

101.3

1151

6051

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

99.9

525

1952

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

98.7

1643

9860

R04.2

ICD-10 Finland

Haemoptysis

3.2

98.3

414

1358

WW200

NOMESCO Finland

Immunization

4.2

97.7

268

660

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

16.0

95.8

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.3

95.1

141

198

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

9.1

94.4

116

130

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

93.3

1537

9168

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

92.1

3109

22815

ZX108

NOMESCO Finland

Inhalation

8.5

91.6

119

143

R4110

NOMESCO Finland

Physiotherapy

1.8

90.9

1929

12423

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

90.6

2132

14144

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

25.4

90.2

XG466

NOMESCO Finland

Sleep oxymetry

3.5

90.1

317

929

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

89.8

585

2422

J01AA02

ATC

doxycycline; systemic

1.8

88.3

4923

41254

R99

ICPC

Respiratory disease other

4.6

87.4

213

478

R81

ICPC

Pneumonia

3.2

87.4

359

1159

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

86.7

640

2806

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.6

86.2

297

858

L88

ICPC

Rheumatoid/seropositive arthritis

3.3

84.3

339

1080

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.8

84.0

453

1704

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

83.7

523

2120

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.2

83.0

226

553

J01FA06

ATC

roxithromycin; oral

1.7

82.5

2518

17823

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

82.5

1531

9425

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

80.8

1891

12444

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

80.4

1064

5866

H02AB07

ATC

prednisone; oral

2.0

80.1

1028

5608

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.5

78.7

130

205

R28

ICPC

Limited function/disability (R)

4.8

75.3

174

374

GDA10

NOMESCO Finland

Biopsy of lung

16.2

75.3

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

75.0

1364

8313

R05

ICPC

Cough

1.8

74.4

1493

9368

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.6

71.0

136

248

WX726

NOMESCO Finland

High-flow oxygen therapy

18.8

70.9

L04AD02

ATC

tacrolimus; systemic

7.2

70.6

105

148

GX2C5

NOMESCO Finland

Short-lasting oximetry

9.7

68.9

ZXE00

NOMESCO Finland

One hour or less

1.6

68.6

2442

17738

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.5

68.6

460

1924

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

68.2

958

5366

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

14.2

68.1

XX9XE

NOMESCO Finland

Other ultrasound examination

7.1

68.0

103

148

J43.8

ICD-10 Finland

Other emphysema

10.8

67.9

N02AA01

ATC

morphine; systemic, rectal

3.7

67.2

216

595

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.6

66.6

221

622

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.3

66.6

177

425

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

66.1

1161

6972

N02AX02

ATC

tramadol; systemic, rectal

1.6

65.5

2821

21355

J01CA04

ATC

amoxicillin; systemic

1.7

64.4

4792

41106

L04AA24

ATC

abatacept; parenteral

11.9

64.3

L04AA01

ATC

[U] ciclosporin

4.9

64.0

143

299

ZX120

NOMESCO Finland

Intravenous

2.1

63.8

706

3633

XX2RW, ,

NOMESCO Finland

5.5

62.8

123

229

F1246, ,

NOMESCO Finland

16.9

62.6

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

61.4

1179

7254

L04AB01

ATC

etanercept; parenteral

5.2

61.2

127

249

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

60.8

2196

15887

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

14.7

60.5

M01CB01

ATC

sodium aurothiomalate; parenteral

4.6

60.3

145

322

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

27.5

60.2

Z3226

NOMESCO Finland

Physiotherapist

1.7

60.1

1226

7669

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.6

59.7

199

562

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

22.1

59.7

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.4

59.2

118

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

59.1

869

4924

JN4AD

NOMESCO Finland

Body CT examination

1.9

58.6

802

4438

120

Kela drug reimbursment

Hypogammaglobulinaemia

22.2

57.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

57.0

692

3674

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

56.4

274

972

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

19.3

56.2

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

55.0

752

4154

I50.0

ICD-10 Finland

Congestive heart failure

2.0

54.9

710

3849

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

54.7

905

5312

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.4

54.4

204

622

R03BA02

ATC

budesonide; inhalant

1.7

54.0

1060

6538

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

53.5

725

3992

M34.1

ICD-10 Finland

CR(E)ST syndrome

9.1

53.3

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.4

53.2

139

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.2

53.1

143

347

A02BC05

ATC

esomeprazole; systemic

1.5

53.0

2472

18773

A02BC01

ATC

omeprazole; systemic

1.6

52.7

1820

12940

J43.2

ICD-10 Finland

Centrilobular emphysema

8.6

52.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

52.3

502

2440

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.9

52.3

154

399

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

9.6

52.1

J80

ICD-10 Finland

Adult respiratory distress syndrome

9.0

51.9

F2680, ,

NOMESCO Finland

13.8

51.9

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

13.8

51.9

Z3231

NOMESCO Finland

Registered nurse

1.6

51.8

1785

12675

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

50.9

1888

13617

A03

ICPC

Fever

1.8

50.8

817

4746

J84

ICD-10 Finland

Other interstitial pulmonary diseases

501.9

50.5

M05BA07

ATC

risedronic acid; oral

2.8

50.2

259

949

C07AB07

ATC

bisoprolol; oral

1.5

49.9

3450

28249

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

48.8

209

690

5AB14, ,

NOMESCO Finland

20.7

48.7

Z2221

NOMESCO Finland

Medical doctor

1.6

48.6

1651

11656

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.7

48.5

157

435

J12.8

ICD-10 Finland

Other viral pneumonia

5.1

48.0

100

197

Z51.5

ICD-10 Finland

Palliative care

1.9

47.8

670

3723

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

10.9

47.7

J96.0

ICD-10 Finland

Acute respiratory failure

3.8

47.7

146

389

A07AA02

ATC

nystatin; oral

2.2

47.5

447

2155

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.2

47.4

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

47.1

532

2745

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

47.0

342

1480

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

76.5

47.0

R03BA01

ATC

beclometasone; inhalant

1.7

46.7

886

5395

WZC30

NOMESCO Finland

Teaching

1.7

46.7

1026

6504

L04AB04

ATC

adalimumab; parenteral

3.9

46.6

138

359

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.4

46.4

118

274

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

46.2

431

2070

R03BA05

ATC

fluticasone; inhalant

1.7

45.8

1042

6663

J01FA10

ATC

azithromycin; systemic

1.5

45.6

2896

23165

G47.3

ICD-10 Finland

Sleep apnoea

1.6

45.6

1340

9130

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

45.4

1391

9566

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.3

45.0

173

536

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

44.4

2603

20471

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

44.3

583

3170

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

44.2

689

3956

Z57.2

ICD-10 Finland

Occupational exposure to dust

7.5

44.0

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.5

43.9

153

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

43.8

824

5000

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.4

43.4

155

458

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.5

42.9

106

241

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

10.8

42.6

XJC10

NOMESCO Finland

Oesophageal pH monitoring

6.5

42.5

107

R03DC03

ATC

montelukast; oral

1.7

42.4

863

5349

J01FF01

ATC

clindamycin; systemic

1.5

41.3

1598

11533

E0000UV, ,

ATC

1.4

39.6

2349

18398

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

39.5

355

1678

R06AE07

ATC

cetirizine; oral

1.4

39.5

2265

17629

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

8.2

39.3

M35.1

ICD-10 Finland

Other overlap syndromes

7.0

38.9

XPX04

NOMESCO Finland

Angioscopy

10.1

38.9

M05.1

ICD-10 Finland

Rheumatoid lung disease

137.5

38.7

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

4.0

38.5

109

275

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

38.4

293

1294

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.1

38.2

D07AC01

ATC

betamethasone; topical

1.4

38.1

2129

16462

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.0

37.8

456

2404

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

37.8

457

2412

J20

ICD-10 Finland

Acute bronchitis

1.8

37.2

581

3330

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

37.1

1113

7576

TGD00

NOMESCO Finland

Needle biopsy of lung

5.8

37.0

116

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.9

36.7

168

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.7

36.3

115

314

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

36.0

472

2558

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.4

35.9

262

1135

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

35.8

863

5572

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

35.7

295

1348

M04AA01

ATC

allopurinol; systemic

1.6

35.3

1040

7042

A02BC03

ATC

lansoprazole; oral

1.4

35.0

1769

13384

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

34.6

434

2318

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

34.5

318

1518

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

34.4

424

2251

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.0

34.0

148

494

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.6

34.0

179

M33.2

ICD-10 Finland

Polymyositis

8.4

33.8

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

93.1

33.7

J01DB01

ATC

cefalexin; oral

1.4

33.7

4845

43698

JN4BD

NOMESCO Finland

Extensive body CT

1.7

33.6

732

4602

L01AA01

ATC

cyclophosphamide; systemic

5.8

33.6

106

R06.2

ICD-10 Finland

Wheezing

2.3

33.5

273

1240

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

33.5

220

909

J94.1

ICD-10 Finland

Fibrothorax

38.4

33.4

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.8

33.4

158

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

33.3

292

1366

XG460

NOMESCO Finland

Short time oxymetry

3.1

33.2

142

469

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.4

33.1

195

N03AX16

ATC

[U] pregabalin

1.5

32.7

1375

10023

WX722

NOMESCO Finland

PEEP

2.1

32.5

325

1600

H02AB04

ATC

methylprednisolone; systemic

1.6

32.4

851

5601

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

12.4

32.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

32.2

1848

14259

J99.0

ICD-10 Finland

Rheumatoid lung disease

318.7

31.9

Z2446

NOMESCO Finland

Social worker

2.0

31.7

371

1934

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

165.8

31.7

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

31.5

634

3901

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

31.4

2161

17186

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.9

31.3

139

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

31.3

1997

15677

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

31.3

729

4658

GAA31

NOMESCO Finland

Thoracoscopy

6.3

31.2

GX2D5

NOMESCO Finland

Sleep oximetry

5.7

31.1

100

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

31.0

2264

18174

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

30.9

2215

17718

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

30.6

2547

20860

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.1

30.6

203

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

30.5

296

1441

C01DA14

ATC

isosorbide mononitrate; oral

1.5

30.5

1290

9398

XG405

NOMESCO Finland

Education on PEF monitoring

3.3

30.4

117

363

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.2

30.0

SPAT1262

SPAT

Handing over of treatment supplies

1.5

30.0

1170

8383

N02BE01

ATC

paracetamol; systemic, rectal

1.5

30.0

5379

49810

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

29.8

924

6310

J67.0

ICD-10 Finland

Farmer lung

9.5

29.7

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.2

29.7

119

SPAT1325

SPAT

Vaccination

1.4

29.6

2166

17356

1XC02, ,

NOMESCO Finland

4.6

29.6

150

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

29.6

266

1258

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.4

29.6

105

310

J45.8

ICD-10 Finland

Mixed asthma

2.4

29.4

208

889

J01FA15

ATC

telithromycin; oral

1.8

29.4

512

3025

A01AB09

ATC

miconazole; local oral

1.7

29.4

525

3124

AN1

Coronary angiography

1.6

29.3

869

5875

2AX04, ,

NOMESCO Finland

66.3

28.9

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

28.5

266

1276

N02AA05

ATC

oxycodone; systemic

1.5

28.5

1227

8954

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.4

28.5

105

1CX01, ,

NOMESCO Finland

11.2

28.4

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.0

28.4

197

J98.4

ICD-10 Finland

Other disorders of lung

8.3

28.2

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

7.7

28.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

27.9

1504

11426

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

27.8

805

5409

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

28.6

27.5

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.6

27.2

164

651

J05AB11

ATC

valaciclovir; oral

1.6

27.1

769

5140

J93.8

ICD-10 Finland

Other pneumothorax

5.0

27.0

114

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

26.8

140

517

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

26.8

3802

33463

RK110, ,

NOMESCO Finland

4.1

26.7

180

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

26.6

179

748

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.9

26.5

126

443

RK320, ,

NOMESCO Finland

3.8

26.4

208

L04AC07

ATC

tocilizumab; parenteral

7.9

26.4

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

26.4

374

2077

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.5

26.3

269

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.5

26.3

140

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

8.7

26.3

SPAT1263

SPAT

Sampling

1.3

26.3

2377

19584

J01FA09

ATC

clarithromycin; systemic

1.4

26.2

1537

11827

ZXA10

NOMESCO Finland

Bilateral

1.4

26.2

1150

8409

B01AA03

ATC

warfarin; systemic

1.4

26.1

1490

11414

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

26.0

1428

10868

R03AK11

ATC

formoterol and fluticasone; inhalant

2.6

25.9

156

619

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

25.9

1068

7713

XA421

NOMESCO Finland

Nocturnal polygraphy

6.3

25.2

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.5

25.2

137

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

25.0

150

594

WX872

NOMESCO Finland

Intensive care

1.9

25.0

352

1949

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

25.0

362

2022

R4190

NOMESCO Finland

Nutritional therapy

2.3

25.0

200

902

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

25.0

685

4538

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

25.0

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

24.8

358

1998

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

24.8

1047

7590

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.7

24.7

123

L04AB05

ATC

certolizumab pegol; parenteral

7.5

24.6

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.7

24.5

210

I73.0

ICD-10 Finland

Raynaud syndrome

3.2

24.5

297

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

24.3

1573

12278

318

Kela drug reimbursment

Teriparatide

4.8

24.3

113

N05CF01

ATC

zopiclone; oral

1.3

24.3

1953

15766

J01MA02

ATC

ciprofloxacin; systemic

1.3

24.1

2412

20093

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

24.0

316

1714

3A006, ,

NOMESCO Finland

+∞

24.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

23.9

165

699

M31.3

ICD-10 Finland

Wegener granulomatosis

5.8

23.6

H05AA02

ATC

teriparatide; parenteral

4.9

23.4

105

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

7.5

23.3

UJF32

NOMESCO Finland

Coloscopy

1.4

23.3

1624

12810

5BA08, ,

NOMESCO Finland

4.5

23.3

125

L04AB06

ATC

golimumab; parenteral

5.0

23.2

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

23.2

168

727

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

23.1

1499

11688

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

23.0

485

3015

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

22.9

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

22.9

2207

18250

R29

ICPC

Respiratory symptom/complaint other

1.8

22.8

364

2095

R01AD09

ATC

mometasone; nasal

1.3

22.5

2156

17797

L04AA17

ATC

[U] adalimumab

6.8

22.5

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.2

22.4

272

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

22.3

1388

10742

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

22.3

531

3400

WX723

NOMESCO Finland

CPAP therapy

2.1

22.3

206

985

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

22.3

361

2086

J46

ICD-10 Finland

Status asthmaticus

2.3

22.2

171

759

C03DA01

ATC

spironolactone; oral

1.5

22.2

798

5596

1240

FHL

Bronchoscopy

3.1

22.0

301

D07AC13

ATC

mometasone; topical

1.4

21.9

1563

12354

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

21.9

325

1830

291

Kela drug reimbursment

Tofacitinib

8.5

21.9

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.5

21.7

218

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

4.0

21.7

154

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.9

21.6

282

1524

A10AC01

ATC

insulin (human); parenteral

1.6

21.6

479

3014

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

21.6

967

7072

H02AB09

ATC

hydrocortisone; systemic

2.4

21.5

143

596

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.2

21.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

21.4

833

5935

R01AD12

ATC

fluticasone furoate; nasal

1.4

21.2

1316

10168

3006

Kela drug reimbursment

Baricitinib

9.0

21.2

WX002

NOMESCO Finland

Sedation and analgesia

1.4

21.1

1159

8782

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

21.0

455

2845

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.0

21.0

299

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.9

20.9

100

353

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

20.8

125

496

N03AX12

ATC

[U] gabapentin; oral

1.4

20.8

906

6587

R03BB07

ATC

umeclidinium bromide; inhalant

3.5

20.8

200

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

20.8

298

1660

R03BB01

ATC

ipratropium bromide; inhalant

1.9

20.8

289

1595

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.0

20.7

R74

ICPC

Upper respiratory infection acute

1.4

20.7

1179

8981

A10AB05

ATC

insulin aspart; parenteral

1.6

20.7

460

2895

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

20.6

193

928

B02.9

ICD-10 Finland

Zoster without complication

1.7

20.6

413

2532

RS123, ,

NOMESCO Finland

15.8

20.5

R01AD08

ATC

fluticasone; nasal

1.4

20.5

1341

10441

R03AC03

ATC

terbutaline; inhalant

1.5

20.5

710

4941

R03AC13

ATC

formoterol; inhalant

1.8

20.4

298

1670

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

20.4

563

3732

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

7.5

20.3

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.2

20.3

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.4

20.3

114

M05BX04

ATC

denosumab; parenteral

1.7

20.1

381

2300

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

20.1

172

799

J02AC01

ATC

fluconazole; systemic

1.3

20.0

1703

13777

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.3

20.0

156

697

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

20.0

609

4123

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

19.9

152

673

XQ800

NOMESCO Finland

Prick test

1.8

19.8

292

1642

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.5

19.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

19.7

322

1865

WX882

NOMESCO Finland

High dependency care

2.1

19.7

184

884

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

29.0

19.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

19.6

316

1825

ZXA00

NOMESCO Finland

Right side

1.3

19.5

1612

12978

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.6

19.4

176

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.4

19.4

205

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.8

19.3

158

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

19.2

189

927

R76.0

ICD-10 Finland

Raised antibody titre

6.5

19.2

C09AA05

ATC

ramipril; oral

1.3

18.9

1694

13781

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

18.9

318

1858

NDG30

NOMESCO Finland

Fusion of wrist, total

4.6

18.9

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

6.4

18.8

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

18.6

638

4426

ZXD05

NOMESCO Finland

Urgent procedure

1.3

18.6

1694

13811

M10.9

ICD-10 Finland

Gout, unspecified

1.6

18.6

493

3237

R03AC12

ATC

salmeterol; inhalant

1.8

18.5

289

1652

WX402

NOMESCO Finland

General anaesthesia

1.4

18.4

1026

7776

J02AC03

ATC

voriconazole; systemic

6.4

18.3

XF402

NOMESCO Finland

ECG with work load test

1.5

18.3

669

4700

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

18.3

1168

9044

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

18.3

1657

13495

L04AA29

ATC

[U] tofacitinib

7.1

18.2

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

18.0

452

2929

J05AB01

ATC

aciclovir; systemic

1.4

18.0

1109

8536

J01DA01

ATC

[U] cefalexin

1.3

18.0

3423

30522

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

18.0

2412

20638

R03DA04

ATC

theophylline; systemic, rectal

1.7

17.9

362

2225

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

17.9

468

3063

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.2

17.9

113

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

17.8

315

1866

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

6.7

17.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

17.8

476

3130

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

17.8

1640

13379

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.8

17.7

140

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

17.7

159

753

M33.1

ICD-10 Finland

Other dermatomyositis

13.7

17.7

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

66.8

17.7

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.4

17.7

119

499

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

17.7

423

2711

A46

ICD-10 Finland

Erysipelas

1.4

17.7

913

6829

M25.5

ICD-10 Finland

Pain in joint

1.3

17.6

1502

12121

SPAT1260

SPAT

Consultation of another employee

1.4

17.4

987

7491

M01CB03

ATC

auranofin; oral

3.5

17.4

165

D07AB08

ATC

desonide; topical

1.5

17.4

556

3799

M05BA06

ATC

ibandronic acid; systemic

2.3

17.4

126

546

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

17.4

516

3471

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.6

17.4

384

SPAT1255

SPAT

Intravenous administration of medicine

1.6

17.3

421

2710

J45

ICD-10 Finland

Asthma

1.5

17.2

480

3185

C08CA05

ATC

nifedipine; systemic

1.6

17.2

407

2602

E000001, ,

ATC

1.4

17.2

994

7571

3AC01, ,

NOMESCO Finland

3.2

17.2

206

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

17.2

227

1234

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

12.6

17.1

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.3

17.1

100

6BA02, ,

NOMESCO Finland

6.6

17.0

A28

ICPC

Limited function/disability NOS

1.3

17.0

1184

9276

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

50.1

17.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

16.9

957

7261

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.9

16.8

127

L01CB

ATC

Podophyllotoxin derivatives

6.1

16.8

N07BA03

ATC

varenicline; oral

2.0

16.8

193

1001

ZXA05

NOMESCO Finland

Left side

1.3

16.8

1475

11937

132

Kela drug reimbursment

Sarcoidosis

3.7

16.8

141

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

4.6

16.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

16.7

1682

13858

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

16.7

159

771

L95

ICPC

Osteoporosis

1.9

16.7

214

1152

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

16.6

641

4548

R03AC19

ATC

olodaterol

4.3

16.6

B01AB04

ATC

dalteparin; parenteral

1.7

16.5

309

1860

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.9

16.3

121

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

16.3

502

3405

R2110

NOMESCO Finland

Giving the first information

1.7

16.3

304

1830

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

16.2

725

5285

XX1VW

NOMESCO Finland

Written report from radiologist

3.4

16.1

169

B01AC04

ATC

clopidogrel; oral

1.3

16.0

1153

9068

Angiography of the heart and coronary arteries

1.5

16.0

473

3179

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.9

16.0

263

J01GB01

ATC

tobramycin; inhalant, parenteral

18.5

16.0

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

16.0

1926

16211

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

15.9

382

2451

WPA11

NOMESCO Finland

Developing a plan for palliative care

6.4

15.8

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

15.8

879

6647

H26.3

ICD-10 Finland

Drug-induced cataract

4.0

15.7

111

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.4

15.6

105

441

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.1

15.6

103

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

15.5

400

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

15.5

218

1209

AK3

BLTX (both lung transplants)

160.4

15.5

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.6

15.4

336

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

15.4

132

615

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

15.3

1792

15009

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

15.3

655

4736

C10AA03

ATC

pravastatin; oral

1.5

15.3

474

3219

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.0

15.3

216

R01AD58

ATC

fluticasone, combinations; nasal

1.4

15.2

909

6947

ZX114

NOMESCO Finland

Intramuscular

2.7

15.2

293

J94.8

ICD-10 Finland

Other specified pleural conditions

2.2

15.1

121

548

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.2

15.1

181

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.3

15.1

176

M54.5

ICD-10 Finland

Low back pain

1.3

15.1

1719

14347

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.8

15.1

266

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.6

15.1

346

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

15.0

1796

15077

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

3.8

15.0

115

B01AB05

ATC

enoxaparin; parenteral

1.3

15.0

1834

15439

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.8

14.9

120

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

14.8

232

1330

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

14.8

192

1039

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

14.8

233

1338

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.6

14.8

309

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

16.5

14.7

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.5

14.6

145

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

14.6

1124

8910

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

11.9

14.5

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

14.5

129

610

NG1DA

NOMESCO Finland

X-ray of knees

2.3

14.5

108

475

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

3.3

14.4

161

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.6

14.4

324

WVA20

NOMESCO Finland

Medicine administration

2.0

14.4

146

725

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

14.4

555

3934

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

14.4

392

2588

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

14.4

455

3103

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

14.3

273

1652

TNG10

NOMESCO Finland

Puncture of knee

2.8

14.3

246

J01XB01

ATC

colistin; inhalant, parenteral

27.2

14.3

M06

ICD-10 Finland

Other rheumatoid arthritis

3.5

14.3

138

R4120

NOMESCO Finland

Occupational therapy

1.6

14.2

334

2131

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.5

14.1

134

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

14.1

2240

19384

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

42.6

14.1

D07XC01

ATC

betamethasone; topical

1.4

14.0

660

4851

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.8

14.0

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.4

14.0

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

14.0

331

2117

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.6

13.9

126

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

13.9

302

1891

I50

ICD-10 Finland

Heart failure

1.8

13.9

223

1288

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.5

13.9

131

A02BA02

ATC

ranitidine; systemic

1.3

13.8

1136

9081

R24

ICPC

Haemoptysis

3.1

13.8

181

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.1

13.8

176

L01BB01, ,

ATC

6.2

13.7

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

13.7

363

ZY010

NOMESCO Finland

Hospital outpatient

1.8

13.7

190

1051

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

13.6

239

1416

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

75.3

13.6

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.5

13.6

133

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

12.0

13.6

A02BA03

ATC

famotidine; systemic

1.7

13.5

231

1357

A41.9

ICD-10 Finland

Sepsis, unspecified

1.7

13.5

229

1342

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

13.5

174

939

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.3

13.5

420

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.4

13.5

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.4

13.5

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

13.5

228

1336

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

13.5

454

3136

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.1

13.4

184

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

13.3

175

951

R60.0

ICD-10 Finland

Localized oedema

1.4

13.3

722

5430

WX740

NOMESCO Finland

Nitrogen oxide therapy

10.5

13.2

WPB10

NOMESCO Finland

Making a convalescent care decision

4.1

13.2

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.5

13.2

126

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

13.1

146

R03BB06

ATC

glycopyrronium bromide; inhalant

3.7

13.0

108

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.9

13.0

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

13.0

276

1720

293

Kela drug reimbursment

Baricitinib

10.0

12.9

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.1

12.9

114

538

S18

ICPC

Laceration/cut

1.2

12.9

2623

23226

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.9

12.9

210

ZX197, ,

NOMESCO Finland

19.1

12.9

WX727

NOMESCO Finland

Estimation of exercise oxygen therapy

50.1

12.8

M79.6

ICD-10 Finland

Pain in limb

1.2

12.8

2111

18295

D07AD01

ATC

clobetasol; topical

1.3

12.7

817

6302

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.3

12.7

413

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.4

12.7

134

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.3

12.7

144

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

70.0

12.6

L04AA11

ATC

[U] etanercept

4.6

12.6

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

32.1

12.6

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.8

12.6

230

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

12.5

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.1

12.5

166

L04AA37

ATC

[U] baricitinib

9.3

12.4

B37.0

ICD-10 Finland

Candidal stomatitis

2.8

12.4

220

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.8

12.4

209

B07.9

ICD-10 Finland

Verruca simplex

1.9

12.4

155

829

N06AX11

ATC

mirtazapine; oral

1.2

12.4

1710

14532

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

12.4

528

3812

TK800

NOMESCO Finland

Hemodialysis

2.0

12.3

126

629

E000002, ,

ATC

1.4

12.3

479

3402

WPA13

NOMESCO Finland

Palliative consultation

4.1

12.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

12.3

444

3109

C02KX04

ATC

macitentan; oral

14.3

12.2

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

4.4

12.1

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.9

12.1

185

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.1

1424

11886

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

12.0

1427

11915

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.8

12.0

202

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

5.2

12.0

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

21.3

12.0

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

12.0

152

818

C10AA01

ATC

simvastatin; oral

1.2

12.0

2843

25496

XX7LW, ,

NOMESCO Finland

5.7

11.9

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

11.9

164

906

Z94.3

ICD-10 Finland

Heart and lungs transplant status

46.7

11.9

L03

ICPC

Low back symptom/complaint

1.3

11.9

1295

10708

RK120, ,

NOMESCO Finland

4.7

11.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

11.8

153

828

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.8

1120

9103

B01AF02

ATC

apixaban; oral

1.3

11.8

831

6493

XG422

NOMESCO Finland

Time-volume spirometry with bronchodialtation

5.8

11.8

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.8

2730

24413

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

11.8

152

823

D11

ICPC

Diarrhoea

1.4

11.7

459

3263

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

11.7

134

697

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

11.7

381

2614

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.7

11.7

239

WX720

NOMESCO Finland

Own respiration

1.6

11.7

242

1499

RS221, ,

NOMESCO Finland

2.4

11.7

310

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

11.6

218

1315

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.7

11.6

ZX100

NOMESCO Finland

Oral

2.2

11.6

410

S97

ICPC

Chronic ulcer skin

1.5

11.6

372

2544

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

11.6

275

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.8

11.6

171

965

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

11.5

486

3503

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

11.5

786

6117

NDF10

NOMESCO Finland

Synovectomy of wrist

5.7

11.5

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

11.5

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

+∞

11.5

UGC02

NOMESCO Finland

Rigid bronchoscopy

5.0

11.4

L03AA02

ATC

filgrastim; parenteral

1.8

11.4

156

859

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

11.4

292

1901

4040, ,

NOMESCO Finland

13.6

11.4

304

Kela drug reimbursment

Dornase alfa

120.2

11.4

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

120.2

11.4

I50.1

ICD-10 Finland

Left ventricular failure

1.5

11.4

337

2265

L28

ICPC

Limited function/disability (L)

1.3

11.4

1082

8792

XF404

NOMESCO Finland

Ambulatory ECG

1.4

11.4

515

3755

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

11.4

112

552

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.3

11.4

357

C10AA05

ATC

atorvastatin; oral

1.2

11.4

2592

23118

WX780

NOMESCO Finland

Remote monitoring CPAP

1.7

11.4

188

1097

R04.0

ICD-10 Finland

Epistaxis

1.4

11.3

469

3367

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

11.3

156

862

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

11.3

108

527

-1, ,

NOMESCO Finland

1.2

11.3

1432

12039

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.2

11.2

403

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

9.6

11.2

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

11.2

123

631

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

11.2

201

1200

R06AX27

ATC

desloratadine; oral

1.3

11.1

1102

9000

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.0

11.1

124

640

SBA00

NOMESCO Finland

Microbiological examinations

1.9

11.1

127

661

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.4

11.1

111

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

8.5

11.0

M48.0

ICD-10 Finland

Spinal stenosis

1.3

11.0

747

5806

J98.2

ICD-10 Finland

Interstitial emphysema

10.0

11.0

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

10.0

11.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

11.0

371

2565

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

10.9

194

1154

S22.2

ICD-10 Finland

Fracture of sternum

3.2

10.9

137

J93.9

ICD-10 Finland

Pneumothorax, unspecified

3.2

10.9

127

A04

ICPC

Weakness/tiredness general

1.3

10.9

766

5982

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

10.9

430

3063

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

10.8

2177

19160

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

10.8

187

3065

AA1AD

NOMESCO Finland

CT of head and brain

1.2

10.8

1663

14256

J86.9

ICD-10 Finland

Pyothorax without fistula

2.6

10.8

237

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.9

10.8

126

660

RS230, ,

NOMESCO Finland

3.4

10.8

108

P01AB01

ATC

metronidazole; oral, rectal

1.2

10.8

1903

16541

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

10.8

400

2816

NDG76

NOMESCO Finland

Fusion of DIP joint

2.9

10.7

165

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

10.7

196

1176

A07EC02

ATC

mesalazine; oral, rectal

1.6

10.7

236

1485

NDG74

NOMESCO Finland

Fusion of first IP joint

4.6

10.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

10.7

3434

31523

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

10.7

152

849

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.5

10.6

349

2398

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

12.9

10.6

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

60.1

10.6

A01AB04

ATC

amphotericin B; local oral

1.6

10.6

258

1663

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

10.6

445

3205

R53

ICD-10 Finland

Malaise and fatigue

1.2

10.6

1235

10277

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.3

10.5

115

G53.0

ICD-10 Finland

Postzoster neuralgia

2.8

10.5

178

D02AE01

ATC

carbamide; topical

1.5

10.5

308

2069

B59

ICD-10 Finland

Pneumocystosis

9.2

10.5

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.8

10.5

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

10.5

256

1652

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

10.4

109

550

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.6

10.4

248

1590

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

10.4

187

1117

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.5

10.4

330

2253

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

5.4

10.4

RK250, ,

NOMESCO Finland

3.2

10.4

121

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.8

10.4

152

857

D72.1

ICD-10 Finland

Eosinophilia

3.9

10.4

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

3.9

10.4

N06DX01

ATC

memantine; oral

0.7

10.4

264

3959

S29

ICPC

Skin symptom/complaint other

1.3

10.4

993

8072

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

10.4

2024

17750

ZX121

NOMESCO Finland

Central venous catheter

4.2

10.3

R04

ICPC

Breathing problem other

1.7

10.3

182

1082

M54

ICD-10 Finland

Dorsalgia

1.4

10.3

502

3708

207

Kela drug reimbursment

Chronic arrhythmias

1.3

10.3

1068

8765

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

10.3

2038

17895

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

10.3

2644

23770

XX4AW, ,

NOMESCO Finland

10.6

10.3

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.8

10.2

186

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

4.7

10.2

SPAT1310

SPAT

Counselling related to known health issue

1.2

10.2

1644

14145

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.2

10.2

400

M01AH02

ATC

rofecoxib; oral

1.3

10.2

702

5463

J01FA01

ATC

erythromycin; systemic

1.4

10.1

521

3881

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.9

10.1

126

675

XG420

NOMESCO Finland

Time-volume spirometry

5.3

10.1

3005

Kela drug reimbursment

Tofacitinib

5.3

10.1

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

5.3

10.1

A11

ICPC

Chest pain NOS

1.4

10.1

444

3223

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

10.0

478

3517

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

9.1

10.0

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

1.9

10.0

117

615

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

9.9

458

3352

M01AE02

ATC

naproxen; oral, rectal

1.2

9.9

2765

25006

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

9.9

347

2418

SPAT1059

SPAT

Spirometry at the office

1.5

9.8

273

1815

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.0

9.8

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

9.7

107

1984

XQ848

NOMESCO Finland

Dermatological photography

1.7

9.7

160

933

M02AA07

ATC

piroxicam; topical

1.2

9.7

1977

17384

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.5

9.7

306

2089

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

9.7

142

802

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.6

3087

28221

E000003, ,

ATC

1.6

9.6

197

1218

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

9.6

477

ZY000

NOMESCO Finland

Hospital inpatient

2.7

9.6

187

N19

ICD-10 Finland

Unspecified kidney failure

1.6

9.6

230

1479

S22.3

ICD-10 Finland

Fracture of rib

1.4

9.5

377

2685

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.5

3467

32021

L17

ICPC

Foot/toe symptom/complaint

1.2

9.5

1484

12713

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

9.5

1500

12864

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

9.5

595

4567

WX730

NOMESCO Finland

Conventional respirator

2.1

9.4

447

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

9.4

1780

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

30.0

9.4

R07.3

ICD-10 Finland

Other chest pain

1.4

9.4

512

3850

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

17.5

9.4

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

9.4

336

SPAT1097

SPAT

Recording of ECG

1.3

9.4

844

6805

M03BX02

ATC

tizanidine; oral

1.2

9.4

2960

27006

M10

ICD-10 Finland

Gout

1.5

9.3

270

1809

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

21.7

9.3

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

9.3

382

ZX140

NOMESCO Finland

Intra articular

2.7

9.3

173

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

4.4

9.3

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.1

9.3

389

D05BB02

ATC

acitretin; oral

1.9

9.3

117

630

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.3

752

5981

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

9.3

137

775

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

10.6

9.3

SPAT1254

SPAT

Administration of medicine

1.3

9.3

822

6614

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

9.2

609

4710

GD1AA, ,

SPAT

1.4

9.2

374

2676

N06AA09

ATC

amitriptyline; systemic

1.4

9.2

491

3678

XJC00

NOMESCO Finland

Oesophageal manometry

3.7

9.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.1

9.1

432

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

2.4

9.1

264

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.3

9.1

277

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.1

2001

17695

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.7

9.1

170

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

4.6

9.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

9.0

808

6507

R06AX22

ATC

ebastine; oral

1.3

9.0

668

5250

WNF00

NOMESCO Finland

Infection source and contact determination

3.4

9.0

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.2

9.0

111

C02KX01

ATC

bosentan; oral

15.6

9.0

J98.6

ICD-10 Finland

Disorders of diaphragm

3.2

9.0

106

L57.0

ICD-10 Finland

Actinic keratosis

1.3

9.0

671

5278

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

9.0

312

2169

C01AA05

ATC

digoxin; systemic

1.3

9.0

550

4209

R52.0

ICD-10 Finland

Acute pain

1.8

9.0

139

798

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

9.0

346

2455

R4130

NOMESCO Finland

Speech therapy

1.8

9.0

135

769

RS220, ,

NOMESCO Finland

2.3

8.9

273

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

24.0

8.9

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

8.9

363

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.4

8.9

255

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

8.9

146

853

OAB50, ,

SPAT

1.5

8.9

282

1928

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

3.9

8.9

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

12.5

8.8

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

1.9

8.8

513

RT271, ,

NOMESCO Finland

7.9

8.8

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.0

8.8

418

T90

ICPC

Diabetes non-insulin dependent

1.2

8.8

1405

12056

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.0

8.8

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.8

8.8

135

774

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.8

909

7450

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.2

8.7

108

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

8.7

645

5068

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.8

8.7

114

622

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

8.7

158

948

D05AX52

ATC

calcipotriol, combinations; topical

1.5

8.7

250

1674

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

50.1

8.7

UDC00

NOMESCO Finland

Ear microscopy

1.4

8.7

374

2708

A06AD11

ATC

lactulose; oral

1.3

8.6

918

7544

M01AB55

ATC

diclofenac, combinations; oral

1.4

8.6

361

2599

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.1

8.6

109

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

8.6

271

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.5

8.6

245

1637

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

8.6

502

3814

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.6

3446

31954

RK220, ,

NOMESCO Finland

3.7

8.6

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.8

8.6

127

720

C08CA02

ATC

felodipine; oral

1.3

8.6

590

4592

RK310, ,

NOMESCO Finland

8.2

8.6

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

8.2

8.6

D68.8

ICD-10 Finland

Other specified coagulation defects

2.5

8.5

199

J43.1

ICD-10 Finland

Panlobular emphysema

9.0

8.5

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

8.5

192

1218

R03BB05

ATC

aclidinium bromide; inhalant

3.5

8.5

NXL00

NOMESCO Finland

Biopsy of muscle

3.5

8.5

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.8

8.5

R06AE09

ATC

levocetirizine; oral

1.3

8.5

536

4121

N06DA02

ATC

donepezil; oral

0.6

8.5

191

2937

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.5

398

2924

WX213

NOMESCO Finland

Lower leg blockade

2.5

8.4

194

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

8.4

206

1332

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

90.2

8.4

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

90.2

8.4

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

2.9

8.4

132

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

8.4

193

1230

F03

ICD-10 Finland

Unspecified dementia

0.6

8.4

110

1932

R78

ICPC

Acute bronchitis/bronchiolitis

1.9

8.3

103

552

F2682, ,

NOMESCO Finland

4.9

8.3

3A064, ,

NOMESCO Finland

3.2

8.3

101

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

3.2

8.3

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

8.3

288

2004

R79

ICPC

Chronic bronchitis

4.1

8.2

I20.09

ICD-10 Finland

Unstable angina

1.4

8.2

360

2613

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.6

8.2

206

1340

I26

ICD-10 Finland

Pulmonary embolism

2.4

8.2

221

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

14.5

8.2

B01AB10

ATC

tinzaparin; parenteral

1.3

8.2

499

3817

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.6

8.1

173

1082

J32.4

ICD-10 Finland

Chronic pansinusitis

2.2

8.1

317

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.1

1234

10527

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.5

8.1

198

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

8.1

288

2014

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.8

8.1

107

587

M32

ICD-10 Finland

Systemic lupus erythematosus

11.7

8.1

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

8.9

8.0

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

10.0

8.0

Coronary artery bypass surgery

1.6

8.0

159

978

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.3

8.0

236

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

6.3

8.0

K51.8

ICD-10 Finland

Other ulcerative colitis

2.2

7.9

281

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

7.9

611

4827

K51.5

ICD-10 Finland

Left sided colitis

1.8

7.9

104

569

UDM02

NOMESCO Finland

Sinoscopy

1.9

7.9

512

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.9

1267

10860

M60.9

ICD-10 Finland

Myositis, unspecified

2.9

7.9

126

A07EA06

ATC

budesonide; oral, local oral

1.7

7.9

147

890

Z31.5

ICD-10 Finland

Genetic counselling

1.6

7.9

161

998

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.9

7.9

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

13.0

7.9

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

6.6

7.9

J92

ICD-10 Finland

Pleural plaque

7.7

7.9

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

7.8

178

1132

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.8

416

3118

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

8.4

7.8

RT272, ,

NOMESCO Finland

4.0

7.8

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

3.4

7.8

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.9

7.8

445

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

7.8

1375

11895

N17.8

ICD-10 Finland

Other acute renal failure

2.0

7.7

377

SPAT1058

SPAT

PEF monitoring instruction

1.4

7.7

389

2890

D07AA02

ATC

hydrocortisone; topical

1.3

7.7

594

4691

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.0

7.7

106

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.4

7.7

197

4038, ,

NOMESCO Finland

45.0

7.7

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.7

2023

18096

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

7.7

211

1400

602

Kela drug reimbursment

Children's severe malnutrition

15.0

7.7

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

3.1

7.7

101

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.7

1605

14087

K77

ICPC

Heart failure

1.7

7.7

142

858

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

7.7

347

2533

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

7.4

7.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.6

618

4913

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.3

7.6

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1.8

7.6

113

642

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.5

7.6

204

1347

K08.3

ICD-10 Finland

Retained dental root

1.4

7.6

383

2845

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.6

7.6

165

1038

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.8

7.6

111

628

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

18.4

7.6

J01DA08

ATC

[U] cefaclor

1.4

7.6

346

2530

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.0

7.6

102

R13

ICD-10 Finland

Dysphagia

1.4

7.5

368

2721

RK290, ,

NOMESCO Finland

4.1

7.5

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.1

7.5

M01AX17

ATC

nimesulide; oral

1.2

7.5

1280

11029

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

3.4

7.5

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

7.5

306

2196

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

7.5

375

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.5

1084

9198

WW500

NOMESCO Finland

Blood transfusion

1.5

7.5

209

1394

M31.7

ICD-10 Finland

Microscopic polyangiitis

7.1

7.5

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

7.5

208

1386

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

7.4

1603

SAA04

NOMESCO Finland

Special examination of mouth

1.5

7.4

208

1388

M10.0

ICD-10 Finland

Idiopathic gout

1.5

7.4

210

1405

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

7.4

2007

17991

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.3

973

8181

R95

ICPC

Chron obstructive pulmonary disease

1.6

7.3

173

1111

XX9XW, ,

NOMESCO Finland

2.8

7.3

126

6BB16, ,

NOMESCO Finland

+∞

7.3

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

7.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

7.3

340

2496

L04AC14

ATC

sarilumab; systemic

10.9

7.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.3

1528

13407

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

6.8

7.3

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

7.3

484

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.7

7.3

124

734

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.9

7.3

442

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

7.2

182

1186

G04BE08

ATC

tadalafil; oral

3.8

7.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.7

7.2

139

849

I47.2

ICD-10 Finland

Ventricular tachycardia

1.7

7.2

118

690

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.5

7.2

173

FXE00

NOMESCO Finland

Use of ECLA

15.7

7.2

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

15.7

7.2

P70

ICPC

Dementia

0.4

7.2

965

WW409

NOMESCO Finland

Other aferesis

4.3

7.2

WX204

NOMESCO Finland

Axillary plexus blockaced

1.6

7.2

147

912

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

7.2

164

1045

J01DA06

ATC

[U] cefuroxime

1.3

7.2

644

5186

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

7.2

242

1677

K76.9

ICD-10 Finland

Liver disease, unspecified

2.1

7.2

307

N02BF02

ATC

pregabalin; oral

1.5

7.2

246

1711

M81.8

ICD-10 Finland

Other osteoporosis

2.3

7.1

223

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

2.8

7.1

122

Z50.1

ICD-10 Finland

Other physical therapy

1.4

7.1

263

1855

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

7.1

209

1410

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

4.1

7.1

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.1

7.1

322

A01

ICPC

Pain general/multiple sites

1.3

7.1

434

3325

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

6.0

7.1

N05CD07

ATC

temazepam; oral

1.3

7.1

671

5441

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

7.0

1735

15419

M01CC01

ATC

penicillamine; oral

5.6

7.0

K11.2

ICD-10 Finland

Sialoadenitis

1.6

7.0

137

840

I20.0

ICD-10 Finland

Unstable angina

2.1

7.0

276

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.7

7.0

110

636

K07

ICPC

Swollen ankles/oedema

1.4

7.0

263

1859

XG430

NOMESCO Finland

Spiroegometry

10.0

7.0

UJD02

NOMESCO Finland

Gastroscopy

1.4

7.0

245

1710

A02BA04

ATC

nizatidine; systemic

1.3

7.0

411

3128

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

7.0

122

727

M05.0

ICD-10 Finland

Felty syndrome

7.0

B01AC06

ATC

acetylsalicylic acid; oral

1.5

7.0

226

1554

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

7.0

359

2678

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

7.0

511

4011

JN6AD

NOMESCO Finland

CT of torso and neck

1.9

7.0

427

R05CB01

ATC

acetylcysteine; inhalant, oral

1.9

7.0

484

SPAT1281

SPAT

Other administrative function

1.4

7.0

371

2783

RS224, ,

NOMESCO Finland

3.2

7.0

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

6.9

252

1771

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.9

1204

10386

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

2.8

6.9

113

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

6.9

749

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.6

6.9

135

829

R51.80

ICD-10 Finland

Headache

1.3

6.9

590

4723

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.7

6.9

A91

ICPC

Abnormal result investigation NOS

1.5

6.9

237

1649

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1.9

6.9

429

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

4.0

6.9

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.1

6.9

292

SPAT1211

SPAT

Application of soft bandage

1.3

6.9

435

3347

SFA10

NOMESCO Finland

One-surface restoration

1.2

6.9

2525

23119

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

6.8

116

686

NHG22

NOMESCO Finland

Fusion of subtalar joint

2.6

6.8

148

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

3.3

6.8

R49.01

ICD-10 Finland

Functional dysphonia

1.7

6.8

130

794

M13.0

ICD-10 Finland

Polyarthritis, unspecified

2.1

6.8

267

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

6.8

406

3099

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

6.8

875

7335

-44

ICPC

Preventive immunization/medic

1.3

6.8

448

3468

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

2.9

6.8

109

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

6.8

134

826

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.2

6.8

248

XV5WT, ,

NOMESCO Finland

40.1

6.8

EB1WA, ,

NOMESCO Finland

2.7

6.7

126

M05BA01

ATC

etidronic acid; systemic

2.7

6.7

132

E000007, ,

ATC

1.5

6.7

206

1402

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.7

419

3218

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.6

6.7

157

1008

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

3.9

6.7

K22.7

ICD-10 Finland

Barrett oesophagus

1.9

6.7

384

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

7.2

6.7

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

6.7

168

1096

WW300

NOMESCO Finland

Transfer of autologic stem cells

3.3

6.7

ECB20

NOMESCO Finland

Oral alveoplasty

2.1

6.7

269

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.3

6.7

418

3213

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

6.7

205

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.5

6.6

169

1106

L08

ICPC

Shoulder symptom/complaint

1.2

6.6

1052

8998

GDB10

NOMESCO Finland

Wedge resection of lung

4.0

6.6

Z01.2

ICD-10 Finland

Dental examination

1.2

6.6

1958

17634

49099

ICD-8 Finland

Bronchitis, unspecified

2.2

6.6

244

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.0

6.6

317

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.7

6.6

122

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.3

6.6

200

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

3.4

6.5

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

3.3

6.5

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

10.0

6.5

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

10.0

6.5

GDC00

NOMESCO Finland

Lobectomy of lung

2.4

6.5

182

N06AX21

ATC

duloxetine; oral

1.3

6.5

467

3656

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

1.7

6.5

106

621

R03AC18

ATC

indacaterol; inhalant

2.2

6.5

220

E66.8

ICD-10 Finland

Other obesity

1.5

6.5

173

1145

RK520, ,

NOMESCO Finland

3.1

6.4

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

3.1

6.4

SPAT1229

SPAT

Assessment of need for aid

1.3

6.4

435

3378

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

5.3

6.4

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

5.3

6.4

D06BB04

ATC

podophyllotoxin; topical

1.7

6.4

122

744

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.4

6.4

233

1639

TKC20

NOMESCO Finland

Catheterisation of bladder

1.3

6.4

405

3116

C83.1

ICD-10 Finland

Mantle cell lymphoma

2.9

6.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.4

1244

10831

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

14.3

6.4

A04AA01

ATC

ondansetron; systemic, rectal

1.3

6.4

361

2734

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

1.9

6.3

413

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.6

6.3

125

5823

FHL

Lung avobiopsy and wedge resection

5.9

6.3

I20.91

ICD-10 Finland

Angina pectoris, unspecified

1.8

6.3

479

R5110, ,

SPAT

1.3

6.3

342

2576

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

3.2

6.3

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.4

6.3

218

1522

M01AH01

ATC

celecoxib; oral

1.2

6.3

880

7438

XG413

NOMESCO Finland

Spirometry with oscillometry

18.0

6.3

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.5

6.3

210

1456

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.3

570

4599

M05BX03

ATC

strontium ranelate; oral

2.5

6.3

143

RJ412, ,

NOMESCO Finland

3.8

6.2

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.0

6.2

317

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.0

6.2

324

JN4CD

NOMESCO Finland

Very extensive body CT

1.5

6.2

196

1342

R01

ICPC

Pain respiratory system

1.9

6.2

352

SPAT1301

SPAT

No procedures

1.2

6.2

1697

15177

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

6.2

875

7397

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.6

6.2

153

995

SFA20

NOMESCO Finland

Two-surface restoration

1.1

6.2

2624

24205

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

6.2

299

2210

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.5

6.2

210

1459

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.7

6.2

555

R07.1

ICD-10 Finland

Chest pain on breathing

2.0

6.2

332

A05AA02

ATC

ursodeoxycholic acid; oral

2.0

6.2

291

N30.2

ICD-10 Finland

Other chronic cystitis

2.2

6.2

212

H01

ICPC

Ear pain/earache

1.3

6.2

416

3231

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

1.8

6.2

460

J01DC02

ATC

cefuroxime; systemic

1.5

6.2

208

1444

WX320

NOMESCO Finland

Spinalanesthesy

1.2

6.2

1291

11308

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

6.2

198

1362

9522

FHL

Synovectomy

3.5

6.1

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

1.9

6.1

354

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.4

6.1

294

2172

M06.3

ICD-10 Finland

Rheumatoid nodule

7.7

6.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

6.1

1276

11173

J98.1

ICD-10 Finland

Pulmonary collapse

2.4

6.1

169

212

Kela drug reimbursment

Gout

1.6

6.1

125

779

WPA44

NOMESCO Finland

Nursing home for palliative care

4.1

6.1

T92

ICPC

Gout

1.6

6.1

120

741

L02

ICPC

Back symptom/complaint

1.3

6.0

367

2809

K74.3

ICD-10 Finland

Primary biliary cirrhosis

2.6

6.0

122

NHQ40

NOMESCO Finland

Amputation of toe

1.7

6.0

574

L86

ICPC

Back syndrome with radiating pain

1.4

6.0

261

1896

EBA00

NOMESCO Finland

Extraction of tooth

1.2

6.0

1650

14759

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

440

572

8.19

319.78

3.5

3.6

—

(3003396) Base excess in Arterial blood by calculation

1761

7016

3.08

318.58

9.0

6.9

1.40

1.07

mmol/l

2.50

1475

5487

(3002179) Metamyelocytes/100 leukocytes in Blood

1258

4112

3.56

315.19

5.6

3.7

0.59

0.71

1.03

528

1412

(3013637) Mi-2 Ab [Presence] in Serum

240

27.67

307.65

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1778

7038

3.11

307.65

9.0

6.9

10.22

12.10

kpa

61.53

1710

6673

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

686

788

9.63

307.65

1.8

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1889

6837

3.50

307.65

2.5

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1889

6810

3.52

307.65

2.6

1.8

—

(3013115) Eosinophils [#/volume] in Blood

4870

26503

4.51

307.65

12.1

5.7

0.21

0.20

e9/l

2.90

4491

22809

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

693

1320

5.77

307.65

1.8

1.5

1.19

1.16

g/l

1.16

671

1244

(3015171) Extractable nuclear Ab [Units/volume] in Serum

977

1539

7.31

307.65

1.3

1.2

1.93

0.90

u/ml

1.01

150

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

767

940

9.13

307.65

2.3

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

4510

24300

3.90

307.65

11.8

5.7

60.23

58.27

22.11

4411

22504

(3023419) Bacteria identified in Sputum by Culture

761

812

10.50

307.65

2.6

2.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

4556

24702

3.93

307.65

12.4

5.9

24.73

26.39

19.60

4460

22889

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

240

27.67

307.65

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

884

2022

4.91

307.65

1.8

38.94

38.37

u/l

0.30

805

1731

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

878

1413

7.04

307.65

1.6

1.4

11.86

18.00

iu/ml

0.63

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

658

850

8.51

307.65

1.3

1.2

18.28

2.14

u/ml

1.87

(40760892) CBC W Ordered Manual Differential panel - Blood

4650

24012

4.43

307.65

13.2

6.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

711

1017

7.74

307.65

1.3

1.2

7.53

2.81

u/ml

0.84

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

523

169

33.61

307.65

1.1

—

(3000492) Spirometry study

1313

4158

3.71

307.65

2.8

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

966

1269

8.79

307.65

2.3

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1133

2829

4.65

307.65

2.2

1.9

1.13

1.41

g/l

4.15

1050

2523

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

959

1218

9.09

307.65

2.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

744

1332

6.19

307.65

2.5

2.2

128.66

127.58

g/l

0.34

319

1010

(3001604) Monocytes [#/volume] in Blood

4797

25569

4.50

307.65

11.5

5.5

0.67

0.62

e9/l

23.69

4379

21727

(3042631) Mycobacterium sp identified in Specimen

654

804

8.95

307.65

2.9

2.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1494

2170

8.68

307.65

1.6

17.33

16.04

u/ml

0.07

(3006504) Eosinophils/100 leukocytes in Blood

4539

24105

4.04

307.65

12.2

5.8

2.72

2.87

4.31

4443

22264

(3037522) Nuclear Ab [Titer] in Serum

2497

5759

6.47

307.65

1.5

1.3

580.53

497.92

titre

1.27

754

1210

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

808

317

29.03

307.65

2.1

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

587

605

10.58

307.65

2.5

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2391

9895

3.26

307.65

2.7

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4911

29838

3.78

307.65

15.3

8.7

4.70

4.27

e9/l

28.57

4542

25767

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

803

853

10.62

307.65

1.2

49.99

0.62

u/ml

—

(4200892) Spirometry reversibility

1252

3638

4.04

307.65

1.9

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1144

1224

11.16

307.65

1.9

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

785

713

12.41

307.65

2.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

602

719

9.14

307.65

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

626

768

8.93

307.65

1.5

1.3

—

(3022096) Basophils/100 leukocytes in Blood

4496

23405

4.10

307.65

12.1

5.8

0.63

0.66

2.93

4404

21598

(3005719) IgG [Mass/volume] in Serum or Plasma

1442

3590

4.89

307.65

4.1

2.6

10.36

10.51

g/l

0.54

1375

3250

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

689

1274

5.94

307.65

1.8

1.4

0.23

0.24

g/l

2.54

664

1204

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2239

7423

4.10

307.65

1.3

60.65

35.48

iu/ml

5.98

781

2273

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1081

1703

7.43

307.65

1.8

1.5

298.22

252.24

titre

0.23

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

462

548

9.01

307.65

2.6

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

974

2472

4.47

307.65

1.5

1.2

248.61

233.40

u/ml

0.19

908

2242

(3019060) Gas panel - Arterial blood

1350

4090

3.92

307.65

4.7

4.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

859

1252

7.77

307.65

1.9

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

1353

4545

3.51

307.65

5.8

3.9

0.87

0.98

0.92

593

1659

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

909

873

11.97

307.65

2.0

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1780

7040

3.12

307.65

9.0

6.9

5.02

5.07

kpa

1.31

1710

6681

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

666

1023

7.15

307.65

1.3

1.2

197.39

128.18

titre

0.25

(42529582) MDA5 Ab [Presence] in Serum by Line blot

240

27.67

307.65

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

648

691

10.32

307.65

1.8

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

609

923

7.19

307.65

11.7

4.5

1436.35

2122.98

iu/ml

0.14

142

127

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1414

2030

8.66

307.65

3.1

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

347

149

24.57

307.65

1.9

1.3

—

(3006315) Basophils [#/volume] in Blood

4802

25659

4.49

307.65

11.4

5.5

0.04

e9/l

6.11

4386

21815

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

620

821

8.25

307.65

2.4

1.4

—

(3019069) Monocytes/100 leukocytes in Blood

4546

24238

4.02

307.65

12.6

6.1

8.91

8.89

0.16

4450

22414

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

714

1031

7.67

307.65

1.3

1.2

12.73

5.94

u/ml

1.45

150

169

(3019198) Lymphocytes [#/volume] in Blood

4815

26179

4.39

307.65

11.7

5.6

1.91

1.89

e9/l

0.20

4443

22724

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

644

740

9.56

307.65

2.3

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

240

27.67

307.65

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

462

548

9.01

307.65

2.6

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

728

1098

7.35

307.65

1.3

1.2

37.01

45.20

u/ml

0.26

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2090

6974

3.97

307.65

1.3

1.2

27.83

12.95

u/ml

2.84

603

2534

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

620

821

8.25

307.65

2.4

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

351

364

10.14

304.28

2.0

1.4

—

(3023368) Bacteria identified in Blood by Culture

3090

16817

2.62

303.11

6.1

4.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

233

121

19.95

301.01

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

326

311

10.99

299.72

2.0

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

325

309

11.03

299.49

2.0

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1220

4039

3.50

298.48

5.8

3.9

0.27

0.32

0.10

452

1181

(3000494) Fungus identified in Specimen by Culture

1541

5931

3.11

293.46

2.2

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

1257

4316

3.38

289.56

5.9

3.9

0.09

0.12

1.09

493

1437

(3039162) Centromere protein B Ab [Units/volume] in Serum

383

475

8.51

289.10

1.3

1.2

57.89

51.85

u/ml

0.13

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

598

1251

5.17

270.74

1.8

1.9

10.86

12.32

mg/l

1.82

559

1144

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

360

459

8.25

265.38

2.1

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4304

28498

2.56

263.64

9.7

6.2

11.29

12.33

umol/l

5.75

4183

27014

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

453

761

6.33

259.43

1.4

1.2

60.08

47.08

u/ml

0.69

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

431

725

6.30

246.32

5.0

2.3

662.40

2659.31

u/ml

1.14

(46235355) HIV 1 and 2 tests - Meaningful Use set

1360

5349

2.96

244.87

1.5

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3155

18630

2.37

242.40

4.1

3.2

1695.11

1756.22

ng/l

0.28

2843

16187

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

152

34.58

240.31

3.0

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

325

418

8.14

237.60

1.4

1.3

7.55

6.65

g/l

2.04

220

285

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3949

25846

2.38

236.71

9.4

6.2

1.20

1.21

mmol/l

4.04

3734

23386

(3028192) IgG subclass 2 [Mass/volume] in Serum

324

418

8.11

236.24

1.4

1.3

2.99

2.88

g/l

0.38

223

288

(3024139) IgG subclass 3 [Mass/volume] in Serum

324

418

8.11

236.24

1.4

1.3

0.50

0.40

g/l

2.51

221

289

(3013707) Erythrocyte sedimentation rate by Westergren method

5152

38097

2.81

236.11

9.5

4.1

18.25

13.78

mm/h

60.93

5021

34738

(3021589) Normoblasts [#/volume] in Blood

3577

22464

2.34

235.77

19.2

10.1

0.00

e9/l

0.75

3059

18224

(4062490) Immunoglobulin typing, IgG

323

419

8.07

234.41

1.4

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

362

539

7.06

232.53

1.3

1.2

—

(3018418) pH of Serum or Plasma

2903

16783

2.34

231.10

5.5

4.1

7.40

1.17

709

3169

(3024980) IgG subclass 4 [Mass/volume] in Serum

407

696

6.18

228.55

1.7

1.6

0.87

g/l

0.01

292

526

(3016502) Oxygen saturation in Arterial blood

1491

6377

2.74

227.56

9.9

7.2

93.80

95.49

17.24

1440

6120

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

346

509

7.13

224.66

2.0

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

353

541

6.85

220.59

2.0

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

940

3181

3.29

217.68

10.8

8.9

24.68

24.25

mmol/l

3.19

905

3055

(3042936) Bacteria identified in Isolate by Culture

1702

7952

2.55

215.70

2.5

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4155

28500

2.31

212.69

10.3

6.9

1.21

mmol/l

1.51

3493

24093

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

275

338

8.46

208.54

1.2

24.96

3.00

u/ml

1.41

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

280

359

8.11

205.00

1.2

68.57

37.11

u/ml

1.03

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

256

294

9.03

204.92

4.0

3.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

278

357

8.10

203.26

1.2

1.1

78.08

78.44

u/ml

0.00

(3038026) Centromere Ab [Units/volume] in Serum

281

368

7.94

202.06

1.2

39.62

70.23

u/ml

0.56

(3007164) IgA [Mass/volume] in Serum or Plasma

1701

8289

2.43

194.00

2.0

1.5

2.82

2.62

g/l

2.66

1239

4761

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

780

2605

3.27

183.05

2.4

1.9

2.13

2.57

ug/l

0.28

709

2260

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5228

41048

2.50

174.24

14.3

7.6

78.69

80.55

u/l

2.23

5120

38430

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

182

169

11.06

169.89

2.0

1.9

54885.68

22038.39

u/ml

0.25

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1997

10980

2.19

167.15

2.4

1.7

1.54

1.41

mg/l

0.62

1650

8513

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

505

1347

3.98

166.17

1.6

52.66

5.14

iu/ml

0.91

118

316

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

982

3935

2.77

165.67

5.9

3.8

5.14

5.15

kpa

0.13

944

3701

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

951

3748

2.81

165.63

5.7

3.7

2.24

1.80

mmol/l

3.10

760

2738

(1616796) Gas panel - Central venous blood

505

1352

3.97

165.29

5.1

3.8

—

(3009343) pH of Capillary blood

971

3883

2.77

164.38

5.8

3.8

7.43

7.42

3.80

184

480

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2581

15936

2.04

156.51

5.2

3.1

34.91

36.51

u/l

0.39

2470

14992

(3011412) CD3 cells [#/volume] in Blood

270

449

6.23

155.38

2.3

2.0

1.00

1.12

e9/l

1.29

250

400

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

374

839

4.67

154.24

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

370

835

4.64

151.43

1.3

1.4

39.16

14.09

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

211

277

7.84

151.17

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

211

277

7.84

151.17

1.3

1.1

—

(36304419) Bacteria [Presence] in Urine

2494

15354

2.02

151.13

4.6

3.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

211

278

7.81

150.70

1.3

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1007

4279

2.61

150.18

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

749

2731

2.97

149.84

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

211

280

7.76

149.77

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

211

280

7.76

149.77

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

211

280

7.76

149.77

1.3

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1238

5808

2.40

149.19

11.1

7.6

123.62

120.12

g/l

6.62

1206

5647

(3002582) Erythrocytes [#/volume] in Urine

2740

17510

1.99

148.61

4.8

3.5

87.99

102.87

e6/l

0.13

2232

13715

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

267

461

6.00

147.85

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

267

461

6.00

147.85

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

267

461

6.00

147.85

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1023

4413

2.57

147.72

2.2

341.40

376.84

nmol/l

4.99

964

4019

(40767503) Oxygen content in Capillary blood by calculation

472

1303

3.83

147.58

3.5

2.5

15.82

15.96

0.27

269

690

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

337

725

4.85

146.15

1.4

131.28

122.07

u/ml

0.19

154

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

870

3491

2.73

145.24

11.5

7.0

25.03

24.79

mmol/l

0.97

860

3460

(40758558) Short blood count panel - Blood

2206

13175

2.03

143.95

10.8

6.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3508

24597

1.94

142.71

6.4

4.8

33.45

34.76

g/l

33.18

3286

22707

(3030467) Casts [#/volume] in Urine by Automated count

2543

16030

1.97

141.68

4.7

3.3

0.39

0.48

e6/l

1.18

2035

12470

(3022217) INR in Platelet poor plasma by Coagulation assay

3881

28202

1.96

141.33

19.1

18.8

1.29

1.37

inr

5.33

1320

7895

(3018095) Leukocytes [#/volume] in Urine

2972

19777

1.94

140.79

5.8

3.9

94.60

108.44

e6/l

0.28

2305

14566

(1175426) CD3 cells/100 lymphocytes in Blood

225

346

6.70

139.69

2.1

1.9

71.98

70.58

0.49

217

323

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1045

4667

2.48

139.60

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

221

336

6.78

138.69

2.1

1.9

16.42

16.58

0.06

216

323

(3015235) Bicarbonate [Moles/volume] in Capillary blood

526

1625

3.44

138.68

4.8

3.0

25.45

24.88

mmol/l

2.22

509

1589

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

229

369

6.40

135.87

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

132

108

12.46

133.65

4.1

4.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1682

9322

2.09

132.80

6.4

3.1

0.81

mmol/l

0.69

1575

8664

(3021901) Oxygen saturation in Capillary blood

426

1188

3.77

130.97

4.5

2.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

159

177

9.19

130.13

3.5

1.7

43.83

61.32

ug/l

1.73

159

169

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

212

330

6.61

130.06

2.3

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

2060

12436

1.97

127.05

3.8

2.7

4.46

4.61

e6/l

0.17

1898

11150

(3028626) Oxygen [Partial pressure] in Capillary blood

474

1455

3.44

125.96

5.5

3.2

7.70

7.97

kpa

3.20

461

1418

(3013826) Glucose [Moles/volume] in Serum or Plasma

4269

32687

1.92

125.14

8.4

4.9

6.83

6.86

mmol/l

0.55

4116

30782

(3001964) Herpes simplex virus Ag [Presence] in Specimen

138

134

10.50

124.80

2.9

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

230

409

5.80

123.39

1.9

1.3

20.33

25.76

iu/ml

0.48

(3026782) Osmolality of Urine

1970

11821

1.96

122.87

4.0

3.0

528.44

549.00

mosm/kgh2o

4.88

1772

10136

(3027315) Oxygen [Partial pressure] in Blood

446

1361

3.45

119.50

6.6

4.4

8.23

8.42

kpa

1.50

437

1329

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

458

1425

3.38

119.00

3.2

2.4

3.82

3.62

g/l

1.80

446

1348

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1343

7115

2.12

117.63

4.6

4.0

266.87

245.19

u/l

5.00

1277

6690

(3008152) Bicarbonate [Moles/volume] in Arterial blood

882

3926

2.45

117.31

8.4

6.7

24.97

24.54

mmol/l

2.69

848

3733

(3012501) Base excess in Blood by calculation

440

1353

3.42

116.42

6.6

4.4

2.70

2.67

mmol/l

0.07

338

920

(3013290) Carbon dioxide [Partial pressure] in Blood

440

1354

3.42

116.29

6.6

4.4

5.01

4.99

kpa

0.18

431

1323

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

160

208

7.86

115.49

1.4

1.1

—

(3024471) HLA-A [Type]

124

117

10.79

114.36

1.0

—

(3024932) HLA-DR beta [Type]

122

113

10.99

113.94

1.0

1.1

—

(3010421) pH of Blood

476

1571

3.19

112.18

6.6

4.3

7.43

7.42

1.26

444

1418

(3037467) Urinalysis macro (dipstick) panel - Urine

4554

36299

1.88

109.52

6.8

4.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1109

5594

2.19

109.39

11.3

6.8

10.68

10.96

mmol/l

0.62

1062

5290

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1109

5618

2.18

108.10

4.1

3.0

229.71

239.86

ng/l

0.31

1045

5164

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2985

21043

1.78

107.74

2.8

2.2

77.75

78.84

nmol/l

1.31

2752

18420

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

490

1688

3.06

107.22

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

213

404

5.42

106.54

1.4

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1461

8247

2.00

106.31

2.9

2.6

20.92

21.96

2.18

1242

6947

(3022948) Iron [Moles/volume] in Serum or Plasma

1604

9366

1.95

105.72

2.8

2.6

11.65

12.37

umol/l

4.02

1518

8669

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1514

8720

1.96

103.59

2.8

2.6

2.25

2.27

g/l

0.67

1411

8024

(40757373) Influenza virus identified in Isolate

114

112

10.35

102.21

2.8

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

918

4412

2.26

101.41

2.1

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1043

5302

2.16

100.13

2.3

2.5

66.26

66.05

g/l

0.35

968

4749

(3010375) cycloSPORINE [Mass/volume] in Blood

143

197

7.40

98.12

44.5

23.7

157.03

105.74

ug/l

8.91

118

162

(3028271) Lactate [Moles/volume] in Capillary blood

330

949

3.61

96.55

2.3

1.9

1.64

1.73

mmol/l

0.90

324

924

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

255

610

4.31

96.53

1.3

1.2

4.35

3.46

u/ml

0.16

105

179

(3014576) Chloride [Moles/volume] in Serum or Plasma

1344

7628

1.96

94.94

11.5

6.7

103.89

104.43

mmol/l

3.68

1344

7621

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

168

284

6.05

94.90

1.5

1.3

1.35

1.98

u/ml

0.41

108

160

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

418

1417

3.09

93.80

3.4

2.2

89.62

88.41

0.52

406

1362

(3035350) Ketones [Presence] in Urine by Test strip

3387

25374

1.71

93.45

4.9

3.9

0.00

estimate

2.37

987

5097

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

127

162

7.98

93.12

2.1

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

163

274

6.08

92.60

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

3375

25300

1.71

92.54

6.6

5.2

0.00

estimate

0.50

954

4698

(3000991) Gas panel - Venous blood

987

5059

2.12

92.14

12.1

7.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

142

209

6.93

91.76

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

142

209

6.93

91.76

1.7

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

271

706

3.96

91.43

1.2

345.99

287.83

u/ml

1.30

176

424

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

142

210

6.89

91.36

1.7

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

3402

25627

1.70

90.98

5.0

4.0

0.00

estimate

1.34

922

4562

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

284

771

3.81

90.38

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2519

17521

1.72

90.38

3.4

2.2

153.52

227.13

u/l

5.34

2376

16315

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

161

274

6.00

90.32

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2181

14603

1.75

89.51

4.7

2.8

2387.81

5426.00

umol/l

4.35

1935

12512

(3013293) Extractable nuclear Ab [Presence] in Serum

14.80

88.69

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

10.46

88.67

1.4

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

131

184

7.25

88.34

2.1

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

184

362

5.20

88.31

2.2

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1328

7697

1.92

87.26

7.8

5.8

1.05

1.04

mmol/l

0.64

1240

7094

(3014111) Lactate [Moles/volume] in Serum or Plasma

1007

5300

2.07

87.25

10.8

6.7

1.45

1.38

mmol/l

1.04

975

5146

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

863

4285

2.17

87.10

1.9

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

230

550

4.30

87.07

1.2

1.1

119.37

113.96

1.42

219

480

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

167

307

5.56

86.39

2.2

2.0

462.32

516.65

e6/l

0.54

139

255

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

791

3813

2.23

85.88

2.0

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

383

1298

3.07

85.87

3.6

2.5

209.94

204.14

0.57

365

1237

(3022313) Gas panel - Capillary blood

637

2804

2.41

85.51

6.2

4.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

239

597

4.12

85.38

1.3

1.2

3.35

4.75

u/ml

1.03

144

251

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

178

352

5.17

84.93

1.1

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

715

3334

2.29

84.01

14.4

9.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1277

7393

1.91

83.81

3.5

2.4

1.93

1.75

7.04

1135

6486

(3048929) Epstein Barr virus Ab [Presence] in Serum

325

1013

3.33

83.77

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2639

18905

1.67

82.65

4.2

3.4

2.34

2.35

mmol/l

3.50

2400

16313

(3028433) Virus identified in Specimen by Culture

120

165

7.39

82.47

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4349

35491

1.70

81.64

6.3

4.9

696.19

1933.39

e6/l

1.96

601

(3017569) Oxygen content in Arterial blood

164

315

5.32

80.85

2.2

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

2039

13709

1.72

80.54

6.3

4.1

84.66

85.09

0.30

2000

13376

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

157

291

5.51

80.49

2.2

2.1

0.21

0.23

e9/l

0.26

139

253

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

177

366

4.95

80.20

1.3

1.2

112.73

123.85

titre

0.12

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

177

366

4.95

80.20

1.3

1.2

134.62

131.72

titre

0.02

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

912

4774

2.06

79.65

4.9

4.0

1.22

mmol/l

2.41

833

4160

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

979

5289

2.00

78.23

2.3

2.2

0.21

0.20

g/l

1.70

914

4901

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

364

1272

2.97

77.22

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

364

1272

2.97

77.22

1.5

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

114

160

7.24

76.92

40.9

32.1

8.06

7.29

ug/l

2.24

102

143

(3002032) Base excess in Venous blood by calculation

1037

5757

1.96

76.47

4.8

3.8

2.25

1.89

mmol/l

2.24

891

4831

(3036489) Thrombin time

457

1818

2.63

75.77

3.2

2.0

21.74

21.82

0.08

416

1626

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

425

4.50

75.53

1.2

96.53

94.00

0.55

180

393

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1759

11519

1.73

75.52

5.2

4.1

401.38

477.41

ng/l

0.34

1561

9791

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1037

5780

1.95

75.50

4.8

3.7

5.88

5.82

kpa

0.96

999

5602

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

222

577

3.95

75.08

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

173

374

4.73

74.33

1.1

—

(40761536) Microorganisms panel - Urine sediment

840

4376

2.06

73.97

5.4

4.2

—

(3012544) pH of Venous blood

1058

5985

1.92

73.52

4.8

3.8

7.41

7.37

1.34

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

177

394

4.59

73.37

2.3

—

(3023520) Reticulocytes [#/volume] in Blood

1001

5605

1.93

71.57

3.4

2.5

73.51

67.77

e9/l

4.14

712

4285

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2951

22328

1.60

70.39

5.2

4.1

95.52

78.54

ng/l

0.11

2378

17030

(3008536) Aspergillus sp Ab [Presence] in Serum

102

8.73

69.74

1.6

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

181

427

4.33

69.71

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2788

20872

1.60

69.14

3.4

2.9

202.67

155.72

ug/l

8.10

2550

18930

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

192

477

4.12

69.06

1.1

1.78

2.47

iu/ml

—

(3014007) Fractional oxyhemoglobin in Arterial blood

751

3858

2.07

68.38

13.8

8.7

92.40

93.93

10.23

745

3842

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1445

9252

1.73

65.88

2.8

2.0

30.04

30.12

0.20

1409

8963

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

139

281

5.03

64.67

2.0

1.5

6.09

6.65

u/l

0.33

124

236

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1435

9231

1.71

64.07

4.2

3.2

1.64

1.94

e6/l

1.09

802

5249

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

597

2879

2.18

63.89

4.8

4.0

24.41

24.06

mmol/l

1.88

586

2810

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2106

14958

1.61

63.76

2.5

2.3

3.22

3.05

mg/l

2.31

1844

12645

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

690

3521

2.08

63.75

1.7

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1033

6065

1.84

63.06

4.8

3.7

—

(3002385) Erythrocyte distribution width [Ratio]

4880

42189

1.66

62.10

36.5

19.8

15.25

15.35

0.67

4848

41354

(3046861) Legionella sp Ag [Presence] in Urine

18.28

61.19

1.1

1.0

—

(3034426) Prothrombin time (PT)

126

7.23

60.87

1.1

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

9.82

60.70

1.3

1.2

45.65

44.41

mg/l

0.05

(3015736) pH of Urine

2680

20296

1.55

60.58

4.2

3.7

5.80

0.01

938

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

211

618

3.50

59.89

1.1

1.54

1.55

g/l

0.07

186

554

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

726

3861

1.99

59.63

14.1

8.5

1.39

1.33

1.17

718

3833

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

125

248

5.12

59.43

1.1

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

723

3846

1.99

59.33

14.2

8.6

0.64

0.66

1.07

715

3814

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3197

25241

1.53

59.24

2.9

2.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

141

316

4.54

57.97

2.4

2.1

566.82

638.91

e6/l

0.69

130

300

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

128

266

4.89

57.68

2.5

38.26

38.25

0.00

154

(4035726) Immunohistochemistry procedure

851

4843

1.87

56.93

1.4

—

(3019977) pH of Arterial blood

150

359

4.25

56.71

2.5

2.4

7.43

7.42

0.48

117

(3034860) Kappa light chains.free [Mass/volume] in Serum

461

2106

2.28

56.11

2.6

3.2

59.96

90.12

mg/l

0.57

331

1738

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

460

2102

2.28

55.95

2.6

3.3

42.64

55.36

mg/l

0.99

328

1734

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1478

9888

1.64

55.70

3.8

3.0

0.97

1.15

e6/l

1.24

846

5865

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

11.25

55.28

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1849

13105

1.58

54.66

5.0

3.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

448

2052

2.27

54.14

2.6

3.2

3.79

3.32

ratio

0.11

161

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

527

2599

2.12

52.94

5.9

5.0

1.76

1.60

3.55

499

2432

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

479

2280

2.19

52.67

3.9

2.9

0.32

0.34

u/ml

0.65

285

1294

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

158

5.96

52.30

2.1

1.9

30.23

29.90

0.06

145

(3006245) CD3-CD19+ cells/100 cells in Blood

157

5.93

51.50

2.1

1.9

9.67

12.06

0.70

140

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5548

50322

1.77

51.34

33.8

16.7

25.22

26.78

mg/l

3.47

5188

40998

(3020891) Body temperature

503

2466

2.13

51.27

5.5

4.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

105

7.22

50.74

1.1

—

(3037756) Immunofixation for Serum or Plasma

337

1407

2.47

50.20

1.5

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

111

6.92

49.49

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

582

3053

2.00

49.31

2.0

1.7

1.60

1.57

g/l

0.34

487

2610

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

270

1025

2.71

48.88

1.4

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

14.92

48.49

1.0

1.1

5.50

1.80

u/ml

—

(3004809) Band form neutrophils/100 leukocytes in Blood

267

1020

2.69

47.74

4.0

3.6

1.60

1.58

0.03

251

881

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

484

2408

2.09

47.37

7.0

4.2

25.02

24.75

mmol/l

1.30

457

2192

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2263

17170

1.49

47.19

3.0

2.6

61.86

64.43

u/l

0.19

2104

15791

(3024354) Oxygen [Partial pressure] in Venous blood

803

4743

1.79

47.03

3.8

3.2

4.50

4.52

kpa

0.07

770

4579

(3029937) Albumin [Presence] in Urine by Test strip

1906

13987

1.52

46.58

5.4

4.4

0.00

estimate

0.88

892

4446

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

969

6075

1.70

45.89

3.1

2.7

10.05

9.27

umol/l

0.40

842

5292

(3044889) 12 lead EKG panel

4280

36887

1.48

45.61

5.7

4.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

261

1009

2.65

45.58

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

107

6.70

44.91

1.1

1.0

—

(3047181) Lactate [Moles/volume] in Blood

404

1917

2.18

44.63

8.2

5.9

1.39

1.34

mmol/l

0.59

370

1701

(3021788) Differential panel - Synovial fluid

253

985

2.63

43.56

1.7

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

434

2143

2.10

43.25

3.4

2.2

371.45

629.90

ug/l

1.39

410

2033

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

279

1143

2.51

43.24

1.8

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

496

2575

2.00

43.11

6.2

5.0

0.86

0.88

0.49

466

2413

(40760888) Immunoglobulin light chains.free panel - Serum

347

1575

2.27

42.71

2.5

3.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

280

1168

2.46

41.74

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

387

1856

2.15

41.57

2.3

0.06

0.05

g/l

0.06

361

1682

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

455

2342

2.01

40.45

2.3

3.15

2.96

g/l

3.54

422

2066

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

364

1723

2.18

40.41

2.4

2.3

0.00

g/l

0.79

338

1554

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

224

4.47

40.29

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

359

1692

2.19

40.29

2.4

2.3

0.00

g/l

-0.00

338

1548

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

422

2121

2.06

40.05

2.4

0.70

1.03

g/l

1.19

374

1797

(3026008) Bacteria identified in Urine by Culture

2263

17590

1.44

39.84

3.8

3.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

478

2526

1.96

39.40

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

478

2528

1.96

39.31

2.3

7.88

7.43

g/l

5.78

445

2247

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

477

2522

1.96

39.25

2.3

3.92

3.70

g/l

1.62

443

2247

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

209

4.55

39.11

1.2

1.05

1.07

ratio

0.35

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

452

2353

1.99

38.89

2.3

10.53

10.21

g/l

0.76

416

2054

(3007853) Bacteria identified in Skin by Aerobe culture

978

6405

1.62

38.52

2.1

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

431

2225

2.00

37.96

4.6

3.9

1.39

1.42

mmol/l

0.30

425

2187

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

264

1120

2.42

37.92

1.3

—

(3018572) Chloride [Moles/volume] in Blood

302

1368

2.27

37.32

8.2

6.8

103.88

105.04

mmol/l

4.24

277

1220

(3039000) Anion gap in Blood

302

1368

2.27

37.32

8.2

6.8

11.60

11.19

mmol/l

1.30

277

1220

(3007566) Smooth muscle Ab [Titer] in Serum

281

1236

2.33

37.20

1.3

1.2

113.53

106.46

titre

0.10

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2427

19342

1.41

36.20

5.3

4.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

385

1945

2.04

35.98

2.3

2.2

36.07

37.36

g/l

3.76

352

1662

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

161

546

3.00

35.96

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

160

4.92

35.77

1.1

25.64

6.20

u/ml

0.55

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1487

10861

1.48

35.38

3.0

3.2

2.48

2.46

mmol/l

6.65

1329

9467

(40768797) Stomach Pathology biopsy report

1073

7342

1.55

34.73

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

353

1760

2.06

34.18

3.9

3.5

—

(3034770) Mitochondria Ab [Titer] in Serum

275

1243

2.27

34.15

1.2

977.50

990.53

titre

0.01

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3574

30693

1.37

32.57

4.4

3.1

65.48

54.72

u/l

5.59

3322

27924

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

317

1546

2.11

32.54

1.6

1.3

—

(3000012) Reticulocyte production index

225

952

2.41

32.53

2.6

2.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1629

12291

1.44

32.19

4.3

3.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

152

534

2.89

31.91

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1290

9380

1.47

30.80

1.3

1.2

1.21

1.77

u/ml

1.74

316

2344

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

283

1371

2.11

29.56

3.4

3.0

1.77

1.71

mg/l

0.53

262

1219

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

182

741

2.50

28.62

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

652

2.59

28.14

4.9

3.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

345

1828

1.94

28.09

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

141

4.65

27.95

2.3

—

(3000060) B lymphocytes [#/volume] in Blood

100

5.44

27.82

2.2

1.9

866.43

1455.56

e6/l

0.21

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

112

5.13

27.52

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

297

1510

2.01

27.23

1.6

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1792

14108

1.38

26.70

1.8

1.6

19.08

20.11

nmol/l

2.21

1590

11966

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

128

452

2.87

26.68

1.7

1.9

4.38

4.71

mg/l

0.28

120

428

(3004119) Hemoglobin [Mass/volume] in Venous blood

597

3773

1.64

26.58

4.6

3.3

126.19

127.85

g/l

1.04

578

3677

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

166

675

2.50

26.20

1.7

1.5

59.39

61.75

0.31

443

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

137

512

2.71

25.67

1.9

1.4

38.11

27.16

2.56

327

(3042111) Morphology [Interpretation] in Bone marrow Narrative

229

1082

2.16

25.53

1.7

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

33.16

25.51

1.0

—

(3017732) Neutrophils [#/volume] in Blood

543

3384

1.66

25.51

3.4

3.3

5.00

5.48

e9/l

0.50

451

2540

(3025941) Bacteria identified in Stool by Culture

439

2584

1.75

25.46

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

162

4.17

25.15

1.3

2.1

197.32

167.91

1.25

151

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

173

733

2.40

24.99

1.2

1.3

183.25

201.92

miu/ml

0.23

270

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

135

510

2.68

24.78

1.6

1.4

14.03

13.06

u/l

0.80

130

488

(3036782) Glucose [Moles/volume] in Pleural fluid

161

663

2.47

24.76

1.4

6.64

6.36

mmol/l

0.47

147

610

(3010838) Calcium [Moles/time] in 24 hour Urine

194

870

2.27

24.60

1.8

4.39

4.77

mmol/24h

0.91

174

738

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

108

4.94

24.57

1.1

1.2

89.59

82.89

0.69

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

6.12

24.51

1.7

1.6

100.21

89.16

au/ml

—

(3004451) EKG impression Narrative

313

3.16

24.37

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

161

673

2.43

23.98

1.5

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

156

4.13

23.78

1.0

1.1

98.76

91.68

1.30

113

(3027273) Bicarbonate [Moles/volume] in Venous blood

495

3077

1.66

23.44

4.6

3.4

25.62

25.14

mmol/l

1.98

470

2985

(3000475) Leukocytes [#/volume] in Synovial fluid

265

1365

1.98

23.43

1.8

1.6

12919.88

15290.10

e6/l

0.31

202

989

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.03

23.22

1.4

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

727

4967

1.52

23.01

2.8

2.4

35.81

47.19

u/l

0.61

656

4231

(3044941) Cell count panel - Synovial fluid

189

864

2.22

22.91

1.7

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

111

4.71

22.84

1.1

1.3

90.53

81.62

0.80

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

4.60

22.59

1.7

1.4

8.20

9.50

ug/l

1.30

116

(3034891) Synovial lining cells/100 cells in Synovial fluid

249

3.32

22.17

1.8

1.3

4.00

3.92

0.02

(40768804) Tissue Pathology biopsy report

2474

20846

1.30

22.15

2.4

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

255

1324

1.96

22.05

1.9

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1546

12207

1.35

21.79

1.9

1.8

1190.99

1159.14

nmol/l

0.61

1166

9103

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

670

4556

1.53

21.62

1.7

1.67

1.56

2.55

565

3843

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

423

2580

1.68

21.52

2.7

1.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

183

852

2.18

21.22

1.2

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

195

935

2.12

20.99

3.1

3.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

128

4.25

20.85

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

155

681

2.31

20.68

1.1

—

(40768795) Lymph node Pathology biopsy report

128

516

2.51

20.66

1.4

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

131

538

2.46

20.33

1.3

14.90

13.22

u/l

0.36

119

493

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.22

20.28

1.2

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

723

5060

1.48

20.24

2.4

2.1

194.44

160.32

ug/g

1.30

596

3948

(3012441) Differential panel - Pleural fluid

166

761

2.21

20.02

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

341

2.84

19.89

1.7

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4105

37203

1.29

19.85

4.1

3.8

14.98

15.00

pmol/l

0.28

3714

33108

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

155

695

2.26

19.73

1.4

1.3

481.23

380.13

u/l

0.66

144

656

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.76

19.59

1.6

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

4.80

19.37

2.2

1.8

7.05

9.18

mg/l

1.41

(3003434) Protein [Mass/volume] in Pleural fluid

200

1001

2.03

19.22

1.5

32.73

31.50

g/l

0.66

175

895

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

170

802

2.15

19.11

7.8

6.3

12.14

12.12

mg/l

0.02

156

738

(3051651) Icteric interference index of Serum or Plasma

347

2.76

18.71

5.5

3.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

129

550

2.37

18.48

1.2

61.87

66.78

u/l

0.38

119

490

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

442

2839

1.60

18.28

3.8

2.7

0.67

0.64

0.74

442

2822

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

374

2.67

18.28

1.4

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.96

18.26

1.3

1.2

111.73

1126.47

ng/l

0.50

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

639

4457

1.48

18.12

4.3

3.8

102.31

97.48

ng/l

0.47

560

3770

(3023183) Ammonium ion [Moles/volume] in Plasma

228

1222

1.90

17.99

2.7

2.5

32.80

34.17

umol/l

0.36

214

1083

(3040151) Glucose [Moles/volume] in Capillary blood

155

724

2.17

17.89

12.9

17.2

7.39

7.45

mmol/l

0.07

139

595

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2753

24032

1.26

17.00

2.2

2.1

90.98

93.27

pmol/l

1.75

1517

12647

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.71

16.78

1.1

—

(40761511) CBC panel - Blood by Automated count

5421

51387

1.36

16.77

26.7

16.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

294

2.81

16.76

4.3

3.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

142

658

2.18

16.75

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1537

12516

1.30

16.70

1.8

1.7

35471252.21

28352009.47

pmol/l

0.15

1232

10137

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2841

24926

1.25

16.66

3.3

2.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

136

622

2.21

16.57

4.3

3.4

55.51

57.53

0.53

122

508

(40768806) Pleura Pathology biopsy report

158

767

2.09

16.54

1.5

1.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.30

16.51

1.1

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.30

16.51

1.1

1.0

—

(3012516) Albumin [Mass/volume] in Urine

2077

17596

1.27

16.41

3.6

3.3

699.90

319.42

mg/l

2.29

1391

11422

(3009508) Creatinine [Moles/volume] in Urine

2116

17976

1.26

16.31

3.6

3.2

7.12

7.40

mmol/l

2.44

1755

14846

(3019550) Sodium [Moles/volume] in Serum or Plasma

5555

52910

1.38

16.26

34.7

20.0

139.07

139.64

mmol/l

47.81

5491

51509

(3000093) Morphology [Interpretation] in Blood Narrative

130

589

2.23

16.21

1.3

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

618

4388

1.45

15.93

3.6

2.7

56.24

61.67

ml/min/173m2

3.22

299

1836

(3050794) Legionella sp Ab [Presence] in Serum

6.16

15.91

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

298

1802

1.69

15.67

1.4

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5557

53014

1.37

15.39

35.0

20.1

4.01

4.00

mmol/l

3.82

5485

51534

(3000570) Elastase.pancreatic [Mass/mass] in Stool

274

1628

1.71

15.38

1.4

288.31

264.76

ug/g

0.44

173

980

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

337

2.60

15.35

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.99

15.24

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

226

1276

1.80

15.16

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

371

2391

1.59

15.13

2.3

1.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

213

2.98

14.37

4.3

3.8

59.58

54.56

1.00

205

(3045788) Cell count panel - Pleural fluid

137

667

2.08

14.29

1.6

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2154

18580

1.24

13.95

4.3

3.8

12.17

9.57

mg/mmol

1.37

1396

11845

(40768443) Skin Pathology biopsy report

372

2451

1.55

13.78

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

160

842

1.92

13.43

1.5

1.9

22.32

23.09

ug/l

0.06

155

822

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.57

13.34

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

143

726

1.99

13.33

1.1

—

(3044927) Protein electrophoresis panel - Urine

135

672

2.03

13.29

1.2

—

(3024928) Oxygen saturation in Venous blood

217

1261

1.75

13.23

3.8

3.1

—

(40768446) Kidney Pathology biopsy report

176

3.09

13.15

1.4

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.34

12.84

1.0

1.3

93.27

79.65

0.62

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

156

833

1.89

12.56

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5542

53134

1.32

12.54

20.5

11.1

25.06

25.67

u/l

1.65

5472

50826

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

375

2.34

12.30

1.4

1.2

—

(3035880) pH of Pleural fluid

408

2.27

12.18

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

307

2.46

11.90

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

307

2.46

11.90

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

237

1453

1.66

11.90

3.0

3.1

0.85

0.83

nmol/l

0.33

183

1104

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

255

2.60

11.80

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.15

11.76

1.1

1.2

76.70

84.16

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

256

2.59

11.71

1.1

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4847

45813

1.24

11.71

5.1

4.7

2.08

mu/l

0.00

4422

41050

(3010726) Horse dander IgE Ab [Units/volume] in Serum

378

2.29

11.65

1.1

1.58

1.11

u/ml

0.27

199

(3022145) Colonoscopy Study observation

756

5844

1.33

11.57

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

328

2.36

11.22

1.5

1.6

8.49

6.90

u/l

0.44

267

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4986

47342

1.24

11.16

6.9

6.4

41.41

40.76

mmol/mol

3.68

4616

43063

(3006922) Hepatitis E virus Ab [Presence] in Serum

269

2.51

11.10

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4986

47366

1.24

10.97

28.8

16.0

73.68

74.56

ml/min/173m2

2.12

4504

39326

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

320

2.36

10.90

1.1

1.2

94.38

88.42

u/l

0.24

272

(3051611) Lipemic interference index of Serum or Plasma

122

632

1.95

10.81

4.8

3.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

104

509

2.06

10.80

1.1

1.35

2.05

u/ml

0.40

268

(3001893) Eosinophils/100 leukocytes in Pleural fluid

227

2.61

10.68

1.4

1.40

2.53

0.97

195

(3044640) Blood type and Crossmatch panel - Blood

2000

17482

1.21

10.66

3.2

2.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

156

879

1.79

10.65

1.6

1.5

4767.19

1984.59

e6/l

0.58

104

640

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

172

2.86

10.56

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

206

2.68

10.50

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

309

2.35

10.35

1.1

1.2

41.60

23.04

u/l

1.34

259

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

714

5567

1.32

10.25

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

440

2.11

10.18

1.1

3.74

3.48

u/ml

0.06

211

(3028308) Erythrocytes [#/volume] in Pleural fluid

142

792

1.81

10.05

1.5

129632.18

57788.38

e6/l

1.05

472

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

177

2.78

10.03

1.1

14.30

2.09

u/ml

1.10

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.80

9.99

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.80

9.99

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.80

9.99

1.5

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

236

2.51

9.89

5.8

4.3

62.61

67.96

mg/l

0.32

164

(3014133) Dog dander IgE Ab [Units/volume] in Serum

322

2.28

9.87

1.0

1.1

2.87

2.61

u/ml

0.07

158

(3023430) Cat dander IgE Ab [Units/volume] in Serum

297

2.34

9.87

1.0

1.1

1.52

2.97

u/ml

0.76

121

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

111

3.26

9.69

1.2

1.5

3.82

7.12

1.09

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

113

593

1.92

9.69

2.5

3.2

—

(3013512) EKG study

1932

16965

1.20

9.58

5.1

4.4

—

(3017704) Immunofixation for Urine

360

2.18

9.48

1.3

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

725

5725

1.30

9.46

2.6

2.4

10.76

7.02

ug/l

3.54

630

4924

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

100

510

1.98

9.33

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

272

1829

1.51

9.25

1.1

335.83

222.27

titre

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

281

2.33

9.23

1.3

1.4

65.03

68.91

0.32

233

(36660697) Celiac disease serology panel - Serum

456

3386

1.37

9.06

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.65

8.97

1.4

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.48

8.82

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.76

8.58

1.3

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.88

8.40

1.2

1.0

10.15

12.36

iu/ml

0.12

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

257

2.31

8.28

1.0

0.22

0.26

u/ml

0.09

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

270

2.27

8.25

1.2

1.1

34.61

30.79

u/l

0.17

239

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

270

2.27

8.25

1.2

1.1

92.29

88.21

u/l

0.12

242

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

569

7230

0.77

8.25

9.8

8.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

356

2583

1.40

8.15

2.7

3.3

4.20

4.40

pmol/l

2.46

305

2245

(3008401) Mugwort IgE Ab [Units/volume] in Serum

431

1.99

8.12

1.1

0.46

1.27

u/ml

1.24

188

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.91

8.02

1.3

1.2

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

2.50

0.64

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

5.19

1.08

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

1.91

2.73

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

4.70

2.11

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

2.78

1.18

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

0.77

0.88

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

1.33

3.12

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

2.68

2.15

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.74

7.86

1.6

1.3

1.03

1.32

mg/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

791

6458

1.26

7.85

3.3

4.0

13.31

24.47

ug/l

1.64

652

5362

(40761539) Cells [Type] in Urine sediment by Light microscopy

143

2.74

7.84

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

423

3180

1.35

7.79

2.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

227

2.35

7.75

1.3

3.87

3.47

mmol/l

0.34

205

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

419

1.97

7.69

1.6

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.41

7.66

1.6

1.3

0.14

1.97

mg/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

386

2.01

7.62

1.1

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

236

2.30

7.56

1.1

10.09

12.00

iu/ml

—

(3012565) Volume of 24 hour Urine

269

2.20

7.47

2.0

2.4

1906.78

1857.23

0.18

224

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1527

13380

1.19

7.41

3.0

2.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

425

1.94

7.40

1.6

1.3

—

(44813793) Dust mix specific IgE antibody measurement

251

2.24

7.39

1.1

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1541

13539

1.18

7.22

1.8

1.6

1.42

1.33

mmol/l

4.31

1243

11202

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

307

2.10

7.15

1.7

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

307

2.10

7.15

1.7

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.02

7.02

1.3

—

(3016750) Collection duration of Urine

350

2.01

7.01

2.1

2.0

481.43

494.54

min

0.43

246

(3041918) Cholesterol [Moles/volume] in Pleural fluid

136

2.66

6.88

1.2

1.95

1.55

mmol/l

1.02

(3020491) Glucose [Moles/volume] in Blood

395

1.94

6.83

2.1

2.2

7.52

6.93

mmol/l

1.04

262

(3025018) Bordetella pertussis Ab [Titer] in Serum

215

2.29

6.83

1.2

—

(21494434) Karyotype in Bone marrow

546

1.79

6.80

1.4

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.71

6.63

1.8

1.4

—

(3045424) Erythrocytes [Presence] in Urine

143

902

1.60

6.58

1.8

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

533

1.77

6.45

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.14

6.32

1.7

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

5620

54718

1.22

6.32

45.5

24.8

39.48

39.76

1.49

5200

50487

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

181

1216

1.50

6.31

1.5

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.17

6.28

1.4

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.34

6.26

1.2

1.3

10.78

141079.23

nmol/l

0.49

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.34

6.26

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

113

683

1.67

6.19

1.7

2.0

—

(3024263) Appearance of Synovial fluid

319

1.98

6.14

1.7

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

204

1414

1.46

6.10

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

203

1406

1.46

6.09

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

5619

54744

1.22

6.05

44.7

24.6

245.04

240.76

e9/l

4.67

5532

53092

(3035941) MCH [Entitic mass]

5620

54756

1.22

6.04

44.4

24.5

30.52

30.44

2.26

5576

53745

(3024731) MCV [Entitic volume]

5620

54756

1.22

6.04

44.5

24.6

92.53

91.59

38.02

5574

53746

(3026361) Erythrocytes [#/volume] in Blood

5620

54759

1.22

6.02

44.6

24.6

4.36

4.43

e12/l

20.31

5514

52893

(3010813) Leukocytes [#/volume] in Blood

5620

54762

1.22

6.00

44.6

24.6

7.77

6.87

e9/l

68.56

5518

52886

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

5.53

5.98

1.9

2.0

1.26

1.51

mg/l

0.40

(3037121) Protein [Mass/volume] in Urine

272

1993

1.38

5.96

2.8

3.0

0.37

0.32

g/l

0.50

137

836

(3000963) Hemoglobin [Mass/volume] in Blood

5620

54771

1.21

5.94

45.0

24.8

131.51

133.95

g/l

26.64

5575

53771

(3006576) Bicarbonate [Moles/volume] in Blood

210

2.20

5.89

5.7

6.9

24.52

24.75

mmol/l

0.12

190

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

244

1760

1.40

5.87

1.1

0.88

1.22

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

107

2.72

5.84

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

347

1.91

5.80

1.0

293.47

285.10

mg/l

0.45

308

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

175

2.29

5.67

5.1

1.7

225.64

111.19

umol/l

0.71

103

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

162

1091

1.50

5.63

1.1

18.28

8.22

u/ml

0.63

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.76

5.61

2.4

3.1

5.43

7.19

mg/l

0.73

(3047189) Immunofixation for 24 hour Urine

323

1.93

5.61

1.7

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

145

2.42

5.60

6.3

7.5

—

(3003181) Sodium [Moles/volume] in Urine

158

1060

1.50

5.59

1.4

1.3

65.78

62.87

mmol/l

0.41

142

859

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

263

2.02

5.50

1.5

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

198

1394

1.43

5.49

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

156

2277

0.68

5.46

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

549

1.69

5.35

1.7

1.3

98158.86

145166.23

e6/l

0.35

381

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

261

2.00

5.25

1.5

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

442

1.75

5.15

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

127

2.45

5.11

1.6

0.37

0.42

ug/l

0.31

(3007919) Fasciola sp Ab [Titer] in Serum

13.35

5.07

1.4

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

113

721

1.58

5.06

1.6

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

322

1.87

5.01

1.9

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

141

2.35

4.97

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

112

718

1.57

4.92

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

112

718

1.57

4.92

1.6

1.4

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.66

4.92

1.1

0.10

0.07

g/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

113

727

1.56

4.89

1.6

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

148

1010

1.48

4.87

1.2

1.3

44.29

41.50

u/l

0.06

131

871

(3003740) Influenza virus B Ag [Presence] in Specimen

443

1.72

4.85

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

112

721

1.56

4.84

1.6

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.99

4.82

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.07

4.78

1.1

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1439

12931

1.15

4.76

1.5

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

185

2.11

4.62

1.4

25.16

22.80

0.17

152

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

738

1.54

4.60

1.6

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.12

4.59

1.5

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

587

6968

0.83

4.59

4.7

4.9

32.26

33.08

1.04

436

4599

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

235

1.96

4.48

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.67

4.46

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.27

4.46

1.2

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

195

2.06

4.43

3.3

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

195

2.06

4.43

3.3

2.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.65

4.36

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.88

4.32

2.1

1.4

41.74

42.21

umol/l

0.03

(3011325) HIV 1+2 Ab [Presence] in Serum

6.26

4.29

1.1

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

101

2.48

4.28

1.2

1.3

18.14

21.51

0.16

(3001729) Color of Synovial fluid

3.04

4.23

2.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

378

1.73

4.23

2.9

2.5

—

(3011648) Oxygen content in Venous blood

446

1.67

4.23

5.4

2.3

11.00

10.95

0.04

446

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

227

1.94

4.19

1.2

1.3

99.04

498.85

ug/l

1.17

115

(3004775) Volume in Urine collected for unspecified duration

509

1.62

4.18

2.2

580.82

649.14

0.85

318

(44816559) Phosphatidylethanol [Mass/volume] in Blood

109

723

1.52

4.17

1.5

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.63

4.05

1.5

1.4

71.07

72.76

0.08

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

4.00

1.5

—

(3020650) Glucose [Presence] in Urine

105

2.39

3.97

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

197

2611

0.75

3.96

1.9

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

565

4790

1.20

3.91

1.6

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.26

3.90

1.3

0.82

0.92

ml/s/173m2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

125

2.25

3.89

6.2

7.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

100

2.41

3.88

1.4

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

213

1.93

3.85

2.9

2.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

240

1864

1.30

3.69

1.4

1.3

—

(40758292) HTLV I+II Ab panel - Serum

2.69

3.65

1.3

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

205

1.91

3.56

1.4

24.08

18.99

0.46

189

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.65

3.55

1.6

1.2

102.38

122.74

ug/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.05

3.52

1.2

—

mmol/l

—

(40768441) Liver Pathology biopsy report

346

1.68

3.51

1.5

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.61

3.46

1.1

9.82

8.60

u/ml

—

(3008295) Osmolality of Serum or Plasma

569

1.52

3.40

1.4

1.3

272.49

278.08

mosm/kgh2o

1.39

428

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

459

1.58

3.36

1.9

4436.03

2905.18

u/l

0.17

179

(3042010) Triglyceride [Moles/volume] in Pleural fluid

101

2.28

3.35

1.3

1.2

0.44

1.79

mmol/l

1.29

(3020191) Ethanol [Moles/volume] in Serum or Plasma

369

1.63

3.26

1.4

1.3

1.13

1.17

promille

0.08

282

(3005011) Chlamydia sp Ab [Titer] in Serum

2.73

3.15

1.5

1.7

—

(3019150) Specific gravity of Urine by Refractometry

1247

11380

1.12

3.12

5.3

4.4

1.02

kg/l

0.14

226

1773

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.50

3.11

7.3

9.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

194

1.86

3.10

1.3

1.1

33.33

40.55

g/l

2.23

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

471

1.53

3.04

1.3

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5039

49220

1.11

3.02

5.3

5.1

6.07

6.08

mmol/l

0.28

4527

43976

(40757494) Bilirubin.total [Moles/volume] in Blood

339

1.63

2.99

2.4

2.6

23.36

30.83

umol/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

123

1669

0.73

2.98

1.7

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.40

2.96

1.2

17.90

19.27

u/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

114

2.11

2.93

1.2

1.3

0.82

87.03

mg/l

0.80

(40765096) Chromosome analysis panel by Banding

184

1.85

2.90

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

397

1.57

2.89

1.3

1.1

32.56

34.34

mmol/l

0.29

336

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.59

2.87

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

480

1.51

2.81

1.5

1.6

13.55

25.93

u/ml

2.28

109

(3023323) Follitropin [Units/volume] in Serum or Plasma

122

897

1.37

2.81

1.4

33.98

30.55

iu/l

0.48

765

(3030313) Adrenal Ab [Titer] in Serum

4.45

2.79

1.3

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.65

2.79

3.6

2.6

0.70

1.27

mg/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.58

2.78

1.1

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

412

1.53

2.70

1.4

124.00

310.68

titre

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

147

1.91

2.64

1.0

1.1

1642.50

1624.56

miu/ml

0.02

147

(3017446) Testosterone [Moles/volume] in Serum or Plasma

466

4030

1.17

2.63

2.6

2.1

12.08

12.06

nmol/l

0.01

399

3498

(3048879) Bone marrow aspiration report

191

1.78

2.61

2.1

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.55

2.61

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.55

2.61

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

328

2755

1.20

2.61

2.8

2.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

294

2451

1.21

2.54

1.1

1.2

128.46

137.34

iu/ml

0.14

858

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.23

2.51

1.5

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

100

727

1.38

2.51

2.4

2.3

0.98

1.32

g/24h

0.87

362

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.81

2.46

1.3

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

326

1.57

2.45

1.9

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

331

2803

1.19

2.43

1.3

47.13

62.83

au/ml

0.47

153

(3002256) Pathology report gross observation

793

7157

1.12

2.41

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.00

2.40

1.3

1.0

—

(3016135) IgD [Mass/volume] in Serum

6.25

2.37

1.4

1.3

242.20

107.90

mg/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.07

2.36

1.3

1.2

355.15

380.17

u/l

0.02

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

139

1.87

2.35

2.0

2.5

—

(3044009) aPTT.lupus sensitive (LA screen)

3.03

2.35

1.4

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

132

1.90

2.35

1.2

1.3

0.35

0.30

g/l

1.33

103

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

140

1.86

2.31

1.0

1.2

22.67

29.25

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

362

3105

1.18

2.30

2.4

29.89

23.58

au/ml

0.23

171

(3027923) C peptide [Moles/volume] in Serum or Plasma

284

1.59

2.30

1.5

1.3

1.22

1.18

nmol/l

0.08

214

(3045414) Leukocytes [Presence] in Urine

288

2424

1.20

2.28

2.3

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1290

0.74

2.27

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

141

1.85

2.27

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

223

1.66

2.26

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

209

1.68

2.22

1.6

1.5

—

(3041184) Isoniazid [Presence] in Urine

5.56

2.21

2.6

1.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

225

1.65

2.20

1.1

1.2

60.67

63.69

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.34

2.18

2.1

5.6

—

(3044290) Cell count panel - Cerebral spinal fluid

122

941

1.30

2.12

1.2

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.56

2.07

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

368

0.54

2.05

1.5

—

(3008898) HLA-B27 [Presence]

142

1123

1.27

2.05

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

2.05

0.0

5.4

—

7.93

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

230

1.61

2.04

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

310

1.52

2.02

1.7

1.8

1.69

2.76

u/field

0.57

210

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.40

2.02

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.22

2.00

4.1

4.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.63

2.00

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

1.85

1.96

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

241

1.58

1.95

1.1

1.6

5.72

10.55

umol/l

1.07

162

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.55

1.94

2.4

4.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.92

1.89

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

129

1.79

1.85

2.0

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

112

873

1.29

1.85

1.4

10.94

10.40

u/l

0.16

705

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

101

777

1.30

1.84

3.0

2.1

24.42

25.78

mg/l

0.10

185

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

269

1.53

1.83

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

776

0.71

1.82

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

153

1.70

1.79

2.1

1.9

—

(3035933) Granulocytes/100 leukocytes in Blood

102

1.87

1.75

2.3

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.90

1.75

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

255

2182

1.18

1.74

3.1

3.4

10693.12

1483.69

u/ml

0.42

209

1868

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4778

46909

1.07

1.71

4.4

4.2

1.34

1.28

mmol/l

8.57

4230

41875

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

1.69

0.0

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

640

1.32

1.67

1.3

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.16

1.66

2.8

2.1

4.33

4.43

mmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.58

1.65

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.44

1.64

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

195

1643

1.19

1.62

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

174

1.61

1.60

1.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.91

1.59

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

198

1.57

1.59

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

472

1.36

1.59

1.0

1.1

14.93

2.73

u/ml

0.77

158

(3014891) Appearance of Pleural fluid

1.82

1.57

1.3

1.2

—

(3019174) dRVVT (LA screen)

2.43

1.53

1.4

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

484

1.35

1.53

1.2

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

642

1.30

1.51

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

1289

1.21

1.50

3.0

3.2

237.12

799.76

u/ml

1.26

142

1178

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

1.49

0.0

1.2

—

11.44

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.43

1.47

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

925

0.76

1.46

1.7

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

411

0.66

1.40

1.0

289.19

326.10

ng/l

0.29

271

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

127

1.66

1.36

1.3

1.2

278.45

256.03

pmol/l

0.10

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.75

1.34

5.4

7.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.04

1.32

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.32

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

104

843

1.24

1.32

1.3

1.7

304.37

299.44

mu/l

0.06

775

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.35

1.29

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.78

1.28

1.2

1.0

—

(40768793) Breast Pathology biopsy report

114

937

1.22

1.28

1.5

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

414

0.67

1.28

1.0

32.06

44.60

ng/l

0.75

269

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.05

1.26

1.1

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

633

1.27

1.26

1.5

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

227

1.46

1.26

3.0

2.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

412

0.68

1.25

1.0

857.25

689.67

ng/l

1.22

264

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.40

1.24

4.0

10.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

717

1.24

1.22

3.3

3.7

26.47

35.51

u/ml

0.82

696

(3028707) Methadone [Presence] in Urine by Screen method

279

1.40

1.22

2.4

2.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

196

1.48

1.21

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

280

1.40

1.20

1.1

286.29

295.11

mg/l

0.14

240

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1852

19238

0.95

1.20

4.3

4.7

21.72

22.18

0.59

858

10207

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

324

0.65

1.19

1.9

1.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.50

1.15

1.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

223

1962

1.14

1.15

1.5

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.73

1.15

1.1

1.12

52.88

u/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

518

1.28

1.14

1.8

2.0

1.60

1.62

u/field

0.02

181

(4034850) Laboratory test

193

1683

1.15

1.13

13.1

11.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5086

50240

1.06

1.13

5.5

5.3

2.50

2.60

mmol/l

12.60

4562

45417

(3032773) Endomysium IgG Ab [Titer] in Serum

352

1.34

1.13

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.33

1.12

1.0

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

1.12

1.3

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.12

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4957

48943

1.06

1.10

4.9

4.7

4.37

4.47

mmol/l

8.25

4448

44469

(3022621) pH of Urine by Test strip

404

3692

1.10

1.09

4.1

3.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

146

1699

0.86

1.09

5.5

4.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

128

1.56

1.08

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

295

1.36

1.07

1.2

1.1

50.27

43.73

mg/l

0.36

245

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

122

1031

1.19

1.07

1.1

1.2

3.85

3.87

mmol/l

0.10

112

958

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.12

1.05

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

121

1.57

1.05

1.6

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

179

0.56

1.04

1.6

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4910

48489

1.05

1.04

4.9

4.7

1.40

1.43

mmol/l

4.78

4373

43725

(3036525) Urea [Moles/time] in 24 hour Urine

2.06

1.02

2.7

3.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

137

1179

1.17

0.99

1.2

1.3

713.19

546.93

mg/l

0.38

125

1107

(3050129) First trimester maternal screen panel - Serum or Plasma

249

0.64

0.98

1.3

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.17

0.98

1.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.97

0.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

108

1.58

0.96

1.9

3.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

216

1.39

0.95

1.4

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

497

1.25

0.94

1.3

1.59

1.46

nmol/l

0.36

438

(3025577) Chromium [Mass/volume] in Blood

418

1.27

0.92

1.7

2.0

1.58

2.23

ug/l

1.98

343

(3015183) Erythrocyte sedimentation rate

159

1.45

0.91

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.63

0.90

12.4

13.4

5.69

5.26

mmol/l

0.54

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.75

0.90

1.6

1.8

—

(3000330) Specific gravity of Urine by Test strip

282

3098

0.91

0.89

4.6

3.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

816

0.82

0.88

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

693

1.20

0.88

1.5

1.3

11.02

0.66

nmol/l

0.49

662

(3027008) Opiates [Presence] in Urine

602

1.22

0.87

1.9

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

217

0.64

0.87

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

217

0.64

0.87

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

216

0.65

0.85

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

216

0.65

0.85

1.4

—

(3028300) Cannabinoids [Presence] in Urine

604

1.21

0.85

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

265

1.32

0.84

1.0

1.1

—

(1002224) Polysomnography panel

161

1424

1.13

0.83

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

1.55

0.81

1.1

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

700

1.19

0.80

1.5

1.3

0.15

0.30

nmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

463

1.23

0.80

2.1

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

116

1013

1.15

0.75

1.2

1.4

101.52

971.45

e6/l

4.12

825

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

605

1.19

0.74

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

160

0.62

0.73

1.6

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.00

0.72

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

117

1.45

0.71

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

654

0.82

0.71

1.6

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

327

1.26

0.70

2.2

2.1

66.00

201.28

ug/min

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.49

0.70

1.5

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.53

0.68

2.0

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.85

0.68

11.8

9.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

227

0.70

0.67

1.4

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

117

0.60

0.67

8.0

6.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

115

1013

1.14

0.67

1.2

1.3

16.69

24.49

e6/l

0.31

784

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

240

1.29

0.67

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

594

1.18

0.67

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

249

1.29

0.67

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

153

1.37

0.66

1.6

1.4

16.71

17.28

pmol/l

0.12

122

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.79

0.66

3.6

2.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

162

1.36

0.66

1.8

1.9

—

(3019225) pH of Specimen

627

5966

1.06

0.65

5.2

4.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

305

0.75

0.65

1.0

1.1

4.26

12.47

nmol/l

—

(3016879) Cocaine [Presence] in Urine

559

1.18

0.65

2.0

1.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

710

1.16

0.62

1.1

68.39

287.68

iu/ml

0.47

145

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

252

1.27

0.62

1.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

599

1.17

0.62

1.9

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.63

0.62

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.67

0.61

4.6

3.9

—

0.00

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

628

1.16

0.61

1.2

1.3

305.89

282.63

pmol/l

0.23

521

(3015076) Soybean IgE Ab [Units/volume] in Serum

105

1.43

0.60

1.1

1.09

0.61

u/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.54

0.59

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

1.54

0.59

2.0

2.7

469.38

601.22

umol/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.2

—

271.77

—

(3041354) Potassium [Moles/volume] in Venous blood

855

1.14

0.59

3.5

2.4

4.13

4.10

mmol/l

0.29

844

(3035285) Chloride [Moles/volume] in Venous blood

855

1.14

0.59

3.5

2.4

105.73

105.69

mmol/l

0.03

844

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

874

1.13

0.59

1.9

1.8

195.97

199.17

pmol/l

0.13

813

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.58

1.7

2.6

0.40

0.38

u/field

—

(4281824) Cell count and differential, peritoneal fluid

486

0.82

0.58

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

304

3248

0.93

0.57

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

839

1.13

0.57

3.6

2.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

192

1764

1.09

0.56

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

341

0.79

0.55

1.2

1.4

27.93

31.35

u/l

0.30

276

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

329

1.22

0.55

1.8

1.4

0.16

0.25

nmol/l

2.04

250

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.62

0.55

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.45

0.55

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

183

0.71

0.55

1.4

1.5

—

(40768800) Prostate Pathology biopsy report

144

1585

0.91

0.55

1.2

—

(3025130) Human papilloma virus identified in Specimen

321

1.22

0.54

1.8

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

213

1.27

0.53

1.0

1.1

1.06

1.14

u/l

0.72

111

(3020911) Cortisol [Moles/time] in 24 hour Urine

143

1.33

0.52

1.5

1.4

111.37

233.14

nmol/24h

0.70

143

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

251

2343

1.07

0.51

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

136

0.66

0.51

1.1

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.56

0.48

1.1

4.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

281

1.21

0.47

1.7

1.6

0.97

0.93

g/l

0.38

281

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.47

0.47

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

146

1.30

0.47

1.0

1.1

0.72

1.83

u/ml

0.76

(3009466) Valproate [Moles/volume] in Serum or Plasma

708

0.87

0.46

4.2

4.5

334.14

350.05

umol/l

0.35

601

(3047352) Trisomy 18 risk [Likelihood] in Fetus

176

0.74

0.45

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

129

1.32

0.45

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

440

1.16

0.45

1.1

—

25.86

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.40

0.45

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2438

24001

1.03

0.45

4.9

5.4

3.43

3.86

ug/l

0.26

2120

21310

(3005033) Fetal Nuchal fold Thickness US

175

0.74

0.44

1.3

1.4

—

(3014271) Vancomycin [Susceptibility]

385

1.17

0.44

2.9

3.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

104

946

1.10

0.42

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

184

0.76

0.41

1.4

2.1

1716.20

18644.13

e6/l

—

110

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

614

1.13

0.41

1.5

1.3

—

nmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.47

0.40

2.6

2.1

—

(4212803) Bone marrow aspirate examination

1.31

0.39

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

269

1.19

0.39

5.0

3.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

165

1538

1.07

0.39

2.3

2.2

126.79

99.24

ug/min

0.44

102

897

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.39

0.0

1.1

—

8.23

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

693

1.11

0.38

1.6

1.5

—

(3011985) Renin [Units/volume] in Plasma

675

1.11

0.38

1.3

1.4

46.81

56.27

mu/l

0.30

589

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

179

1.23

0.37

20.8

18.1

1404.18

1421.33

nmol/l

0.04

174

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

112

1031

1.09

0.37

1.7

4.40

4.67

iu/l

0.09

327

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.39

0.36

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.39

0.36

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

207

1.21

0.36

1.0

1.1

—

(40761535) Cells panel - Urine sediment

506

4881

1.04

0.36

4.5

3.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

135

1.26

0.35

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

1.26

0.35

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

442

1.13

0.34

1.3

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.34

0.34

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

214

2026

1.06

0.34

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

1.24

0.33

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.28

0.32

2.0

2.1

14.40

18.48

umol/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.28

0.32

1.0

1.2

7.83

11.45

u/l

—

(3051593) INR in Capillary blood by Coagulation assay

348

0.86

0.31

7.3

12.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.31

1.9

1.1

1.80

1.76

umol/24h

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

184

1.20

0.30

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

129

1.24

0.30

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

130

0.77

0.29

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

206

0.82

0.29

1.9

2.2

326.00

4423.10

e6/l

—

150

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.23

0.29

1.0

1.1

—

(3003338) MCHC [Mass/volume]

4059

40327

1.02

0.28

40.0

22.1

329.51

331.85

g/l

48.98

4032

39933

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.27

0.27

1.1

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

177

1.19

0.27

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

107

1003

1.07

0.25

1.8

1.6

1.05

0.80

nmol/l

2.03

825

(3002079) Sodium [Moles/time] in 24 hour Urine

197

1.17

0.25

1.4

1.2

134.83

161.39

mmol/24h

0.97

197

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

123

1.22

0.25

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

521

1.09

0.25

1.2

7.32

7.66

mmol/l

0.43

438

(3033923) Metanephrine [Moles/time] in 24 hour Urine

105

1.24

0.24

1.4

1.2

0.85

0.70

umol/24h

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

227

1.15

0.23

1.2

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

265

1.13

0.23

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

389

1.11

0.23

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.32

0.23

1.4

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.22

1.0

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.74

0.22

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

172

1.16

0.22

16.4

12.9

830.55

824.41

nmol/l

0.02

162

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

9.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3008607) Semen analysis panel

0.00

0.21

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

2.21

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

6.7

—

45.58

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.22

0.20

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1347

13636

0.98

0.19

3.0

3.2

0.72

0.82

ug/l

3.28

969

9757

(3026480) Teichoate Ab [Titer] in Serum

1.18

0.19

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.15

0.19

15.5

10.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.15

0.19

1.3

—

609.28

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.15

0.17

1.3

1.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

379

1.08

0.16

3.4

5.1

118.64

55.54

u/ml

0.45

109

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.79

0.15

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

130

1.15

0.15

1.1

—

(3044007) Cell count panel - Peritoneal fluid

159

1.13

0.15

1.7

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

150

0.87

0.14

1.9

2.4

1.24

1.31

ug/l

0.06

140

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

112

1.16

0.14

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

275

1.09

0.14

3.7

6.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

126

1215

1.04

0.14

1.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

1490

14773

1.01

0.14

3.3

3.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.17

0.13

2.5

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

241

0.91

0.12

1.4

1.3

6.05

6.11

mmol/l

0.09

226

(3026692) Albumin [Mass/volume] in Peritoneal fluid

153

1.11

0.11

1.5

1.6

12.59

14.75

g/l

0.38

121

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

0.88

0.11

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

309

1.07

0.10

2.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

248

0.93

0.09

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.09

0.08

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

136

1.10

0.08

1.0

1.1

0.67

2.70

u/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.08

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

205

0.93

0.08

1.1

1.4

1.67

1.55

g/l

0.82

205

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.83

0.07

2.5

2.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.81

0.07

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.80

0.07

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

296

0.95

0.07

1.4

142.67

195.39

pmol/l

0.82

296

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

101

0.89

0.06

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

152

0.92

0.06

1.6

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

121

0.91

0.06

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

127

1247

1.02

0.06

2.0

1.7

25.80

3.62

mg/l

6.41

111

931

(3014051) Protein [Presence] in Urine by Test strip

148

1503

0.98

0.05

3.7

2.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

123

1251

0.98

0.05

6.1

3.8

28.72

29.69

mg/l

0.11

806

(4146454) Self-monitoring of blood glucose

694

1.02

0.04

2.4

2.8

—

(3011288) Drugs identified in Urine by Screen method

393

0.97

0.04

9.4

2.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

475

4776

0.99

0.03

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

198

1963

1.01

0.03

3.3

3.8

55.85

72.73

u/ml

0.51

191

1884

(1617658) Protocol used for examination of sentinel lymph nodes

320

0.97

0.03

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

550

1.02

0.02

2.4

3.1

59.36

46.93

mg/l

0.20

417

(4094501) Cardiovascular stress test using bicycle ergometer

138

1391

0.99

0.02

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

107

0.93

0.02

1.7

1.6

163.90

152.09

ng/l

—

107

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

137

1.02

0.00

2.0

2.2

7.63

8.12

mmol/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

354

0.99

0.00

2.2

1.7

93.06

90.42

umol/l

0.13

354

(3033799) Differential panel - Peritoneal fluid

179

1.01

0.00

2.2

1.8

—

(3006270) Folate [Moles/volume] in Blood

511

1.00

0.00

1.1

1.2

296.57

338.77

nmol/l

0.76

403

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

16.60

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

40.00

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.8

—

14.00

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.2

—

0.30

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.80

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.93

0.00

1.2

1.5

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.29

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.80

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.3

—

2864.44

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1364.44

—

(3002619) Bacteria identified in Specimen by Culture

0.93

-0.00

1.4

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL – ILD, hospital admissions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for ILD, hospital admissions (ILD_HOSPITAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints